Monday, November 08, 2021

OHIO history of Chronic Wasting Disease CWD TSE Prion Disease Wild and Captive to date

OHIO history of Chronic Wasting Disease CWD TSE Prion Disease Wild and Captive to date

In 2020, the Ohio Department of Natural Resources (ODNR) Division of Wildlife identified Ohio's first positive test for CWD in a wild Ohio white-tailed deer in Wyandot County. 


A second positive test was identified in January 2021 during a controlled hunt on the Killdeer Plains Wildlife Area refuge, within 2 miles of the first positive location.



How to collect samples for CWD testing

Watch our YouTube video for proper collection techniques for CWD sampling


Chronic Wasting Disease Detected on Wayne County Farm

Chronic Wasting Disease (CWD) has been detected at a farm in Wayne County.

 
OHIO CWD TSE Prion expands to wild with 2 confirmed positive cases and 26 confirmed positive cases in captive farmed cervid to date

Effective SEPTEMBER 1, 2021 to AUGUST 31, 2022 HUNTING AND TRAPPING REGULATIONS 2021-22

CHRONIC WASTING DISEASE

KNOW THE FACTS

Chronic Wasting Disease (CWD) is a fatal neurological disease of white-tailed deer. There is no strong evidence that CWD is transmissible to humans. The first confirmed case of CWD in Ohio was at a hunting preserve in Holmes County in 2014. Since then, 25 deer, from four captive facilities in Holmes and Wayne counties have tested positive for CWD.

In December of 2020, Ohio confirmed its first CWD-positive wild deer. The mature buck, harvested in late October in Wyandot County, was taken to a local taxidermist as part of routine CWD surveillance. In January of 2021, a positive yearling doe was harvested during a controlled hunt on the Killdeer Plains Refuge. A Disease Surveillance Area (DSA) has been established, and intensive monitoring will continue for at least three years in all of Wyandot and parts of Hardin and Marion Counties.

PROTECT OHIO’S DEER HERD

 Properly dispose of a deer carcass. Be sure to double-bag all high-risk parts (brain, spinal cord, eyes, and lymphoid tissues) and dispose of them with your household trash.

 It is illegal to bring high-risk carcass parts into Ohio from anywhere outside the state , unless the animal is delivered to a Division of Wildlife certified processor or taxidermist within 24 hours.

 Contact a Division of Wildlife district office or state wildlife officer if you see a deer that appears sick, is acting abnormally, or has a visible ear tag.

 The Division of Wildlife has a Disease Surveillance Area (DSA), 2021-01, which includes all of Wyandot County, Jackson, Goshen, Dudley townships in Hardin County and Grand, Salt Rock, Grand Prairie, Montgomery, Big Island, and Marion townships in Marion County.

PRECAUTIONS FOR HUNTERS

A deer infected with CWD typically does not immediately show signs of the disease. As the disease progresses, the animal begins to lose body condition and stagger, carry its head and ears lowered, drool excessively, and show little fear of humans. They will eventually lose body condition and appear weak and emaciated.

 Wear rubber gloves when field-dressing and thoroughly wash your hands and instruments after field-dressing and butchering.

 Bone out the meat from your animal and minimize the handling of brain and spinal tissues.

 Do not eat the brain, spinal cord, eyes, spleen, tonsils, and lymph nodes.

 Do not consume meat from any animal that tests positive for CWD.

 Hunters may have a harvested deer tested at the Ohio Department of Agriculture’s Animal Disease Diagnostic Laboratory. Call (614) 728-6220 for more information. 

DSA RULES INCLUDE:

 The placement of or use of bait (salt, minerals, or any food) to attract or feed deer within the Disease Surveillance Area (DSA) boundaries is prohibited, as is the hunting of deer by the aid of bait.

 Normal agricultural activities, including feeding domestic animals, as well as hunting deer over food plots, naturally occurring or cultivated plants, and agricultural crops are not prohibited in the DSA.

MANDATORY SAMPLING FOR DEER HARVESTED WITHIN THE DISEASE SURVEILLANCE AREA (DSA)

 Mandatory sampling is required for ALL deer harvested Nov. 6-7, and 13-14 as well as the entire seven-day gun season (Nov. 29 – Dec. 5).

In-person sampling is available on Nov. 6-7, 13-14, and Monday (Nov. 29), Tuesday (Nov. 30), and Saturday (Dec. 5) of gun season. To avoid lengthy delays, hunters are encouraged to complete the game check process before presenting their deer for sampling. Staff is available from 8 a.m. to 8 p.m. at the following locations:

BIG ISLAND Wildlife Area Headquarters 5389 Larue-Prospect Rd West, New Bloomington, OH 43341

KILLDEER PLAINS Wildlife Area Headquarters 19100 CH 115 Harpster, OH 43323

WYANDOT COUNTY Fairgrounds 10191 OH 53 Upper Sandusky, OH 43351

Hunters who find it more convenient to use the self-serve kiosks may do so. For hunter convenience, self-serve kiosks are available October 1 through the close of the statewide muzzleloader season (January 11, 2022). Participation is voluntary outside the 11 mandatory days noted above. Instructions for sample submission are provided at the kiosk. Kiosk locations and instructions are available at wildohio.gov.


INCREASED CWD SURVEILLANCE PLANNED FOR WYANDOT, HARDIN, AND MARION COUNTIES

October 26, 2021

Increased CWD Surveillance Planned for Wyandot, Hardin, and Marion Counties

COLUMBUS, Ohio – Testing for Chronic Wasting Disease (CWD) in Ohio’s white-tailed deer population will continue during the 2021-22 hunting season, according to the Ohio Department of Natural Resources (ODNR) Division of Wildlife.

CWD is a fatal neurological disease that affects white-tailed deer and other similar species, including mule deer, elk, and moose. According to the Centers for Disease Control and Prevention, there is no strong evidence that CWD is transmissible to humans.

Two CWD-positive wild deer were confirmed during the 2020-21 hunting season in Wyandot County. A disease surveillance area has been established in response to the confirmed cases, and intensive monitoring will continue for at least three years in Wyandot County as well as portions of Hardin and Marion counties.

Specific regulations apply to hunters who harvest a deer in this location, including mandatory testing on Nov. 6-7, Nov. 13-14, and the seven-day gun season, Nov. 29 – Dec. 5. In-person sampling is available at the Big Island Wildlife Area Headquarters, Killdeer Plains Wildlife Area Headquarters, and the Wyandot County Fairgrounds on those dates. Self-serve kiosks are also available. A list of kiosk locations and instructions can be found at ohiodnr.gov/cwd.

In addition to mandatory testing, the following regulations apply within the disease surveillance area:

Prohibits the placement of or use of salt, mineral supplement, grain, fruit, vegetables, or other feed to attract or feed deer

Prohibits hunting of deer by the aid of salt, mineral supplement, grain, fruit, vegetables, or other feed

Prohibits the removal of a complete carcass or high-risk parts from the disease surveillance area, unless the carcass complies with deer carcass regulations or the carcass is delivered to a certified taxidermist or processor within 24 hours of leaving the area. Additional information on carcass regulations and a complete list of certified processors and taxidermists can be found at wildohio.gov.

Normal agricultural activities, including feeding of domestic animals, as well as hunting deer over food plots, naturally occurring or cultivated plants, and agriculture crops are not prohibited.

To help protect Ohio’s deer herd from CWD, hunters should properly dispose of their deer carcasses by double-bagging all high-risk parts (brain, spinal cord, eyes, and lymphoid tissue) and setting it out with their household garbage for trash pickup. Those without trash pickup can double bag the carcass and take it to a municipal solid waste landfill or bury the carcass at least 3 feet deep on the property of harvest. The proper handling of carcasses, trims, and parts dramatically decreases the odds of spreading CWD.

The Division of Wildlife has conducted routine surveillance for CWD since 2002, with more than 30,000 deer tested. CWD has previously been detected at captive deer breeding facilities in Ohio. CWD has been detected in 26 states and four Canadian provinces.

Hunters may test a harvested deer at the Ohio Department of Agriculture’s Animal Disease Diagnostic Laboratory for a fee. Call (614) 728-6220 for more information.

The mission of the Division of Wildlife is to conserve and improve fish and wildlife resources and their habitats for sustainable use and appreciation by all. Visit wildohio.gov to find out more.

ODNR ensures a balance between wise use and protection of our natural resources for the benefit of all. Visit the ODNR website at ohiodnr.gov.

Editor’s Note: A map of the disease surveillance area is included with this release.



Ohio CWD TSE Prion

FRIDAY, AUGUST 13, 2021

Ohio Annual Deer Program Summary Spring 2021 CWD TSE Prion Update

snip...

In December 2020, routine surveillance detected the first case of CWD in Ohio’s wild deer population. 

snip...

Chronic Wasting Disease Chronic Wasting Disease (CWD) is a fatal disease of the central nervous system of mule deer, white-tailed deer, elk, moose, and reindeer. CWD is caused by abnormal proteins, or prions (not a bacteria or virus), that ultimately destroy brain tissue. CWD can be spread through direct animal-to-animal contact or by contact with saliva, urine, feces, carcass parts of an infected animal, or contaminated materials in the environment (plants and soil). Prions released into the environment through bodily fluids or diseased carcasses are extremely resistant to degradation and can remain infectious for years. CWD is known as a transmissible spongiform encephalopathy, a family of diseases that includes bovine spongiform encephalopathy (mad cow disease), scrapie in sheep, and Creutzfeldt-Jakob Disease in humans.

Since 2002, the Division of Wildlife has conducted statewide CWD surveillance, testing 28,613 deer. In 2020, a record 4,654 deer were submitted for CWD testing. Division of Wildlife staff collected 853 road-killed deer from all 88 counties and hunters submitted 3,176 deer via cooperating taxidermists and processors. An additional 287 deer were submitted by hunters at collection and inspection stations. Additional deer (338) were collected and tested through various means (deer displaying abnormal behavior and/or poor physical condition, found dead under suspicious circumstances, removed in conflict or culling situations, etc.). For the first time ever, CWD was detected in a wild Ohio deer.

Positive Detections in the Wild Population

In December 2020, the Division of Wildlife received test results that a mature buck harvested in southern Wyandot County tested positive for CWD. The buck was presented to a cooperating taxidermist who was aiding the Division of Wildlife with tissue collections as part of our routine disease surveillance. Given the significant delay between the time the deer was shot and when it was ultimately recovered (9 days), only the head was delivered to the taxidermist. Division of Wildlife staff visited the site of the harvest, collected and properly disposed of the carcass, and removed the top layer of soil in an effort to reduce environmental contamination. Upon detection, a 15-township area surrounding the positive location was designated for enhanced surveillance (Figure 11) where hunters were encouraged to submit deer for testing throughout the remainder of the deer season, particularly during the 2-day bonus gun and muzzleloader seasons. Additionally, given the proximity to Killdeer Plains Wildlife Area and Refuge, all deer harvested on the remaining controlled hunts were submitted for testing (n = 171). This additional surveillance produced a second positive, a yearling doe that was harvested during a controlled hunt on the Killdeer Plains refuge.

Additional culling efforts were implemented on the refuge and surrounding area following the deer season to 1) obtain more information about the prevalence and distribution of the disease, 2) reduce population density (aerial surveys revealed an abnormally high deer density within and surrounding the refuge), and 3) potentially remove additional CWD-positive deer from the herd. In three nights of operations, Division of Wildlife staff removed and tested 72 deer with no additional positive detections. 

Disease Surveillance Area

In October 2014, a mature buck from a shooting preserve in Holmes County tested positive for CWD, becoming the first-ever CWD-positive deer in Ohio. The shooting preserve was depopulated in April 2015, and testing revealed no additional CWD-positive animals. Subsequent testing of nearly 300 free-ranging deer in an eight-township area around the shooting preserve failed to detect any CWD-positive deer as well. However, in spring of 2015, two more CWD positive deer were reported from a captive white-tailed deer breeding pen in Holmes County. This herd was depopulated in June 2015, and 16 additional deer tested positive for the disease. In response to these findings, the Division of Wildlife conducted targeted surveillance in the immediate vicinity of the infected facility during the summer of 2015, collecting 18 deer (including two that had escaped from captive facilities), with none testing positive for CWD.

Additionally, the focus area in 2015 was expanded to include two townships in southern Wayne County, and the 10- township focus area was declared a Disease Surveillance Area (DSA, visit wildohio.gov for specific regulations pertaining to a DSA). The 10-township DSA in central Holmes and southern Wayne counties expired on July 31, 2018 after three seasons of intensive surveillance revealed no CWD-positive animals in the wild herd. However, due to the early 2018 discovery of three additional CWD-positives in an eastern Holmes County captive facility, a new, 7-township DSA was established (Figure 12). During the 2020-21 season, 175 hunter harvested deer from DSA 2018-01 were collected at inspection stations during Ohio’s 7-day gun season. Again, CWD was not detected in any of the deer tested.

In April 2020, a female mule deer on a farm in southeastern Wayne County tested positive for CWD. A second mule deer doe tested positive in June 2020, and, following depopulation of the herd in August 2020, one additional whitetailed deer buck tested positive. These additional positives bring the total number of positive detections in captive herds to 25. Given the low prevalence of disease in the facility, low deer densities in the surrounding area, and history of surveillance in the area, no additional action was taken in response to this event.

Figure 11. Enhanced surveillance area covering 15 townships in portions of Wyandot, Marion, and Hardin counties.

Figure 12. Disease Surveillance Area 2018-01 (DSA)


FRIDAY, JUNE 11, 2021

Ohio Confirms 2 CWD Positive Wild Cervid 2020-2021 With Additional 25 deer from four captive deer facilities confirmed positive to date


TISSUE SAMPLE CONFIRMED POSITIVE FOR CHRONIC WASTING DISEASE IN ONE WILD OHIO DEER

December 14, 2020

COLUMBUS, Ohio – The Ohio Department of Natural Resources (ODNR) Division of Wildlife has identified a positive test for Chronic Wasting Disease (CWD) in a wild Ohio white-tailed deer in Wyandot County. The Division of Wildlife is gathering additional details about the adult male deer taken by a hunter on private property. Tissue samples were submitted for testing by a taxidermist and the positive test was identified after results were obtained on Thursday, December 10, 2020.

CWD is a fatal neurological disease that affects white-tailed deer and other similar species, including mule deer, elk, and moose. According to the Centers for Disease Control and Prevention, there is no strong evidence that CWD is transmissible to humans. 

The Division of Wildlife will implement its CWD response plan, which includes enhanced surveillance within a 10-mile radius of the CWD positive deer location in Wyandot County. Mandatory deer disease sample collection will occur on all remaining Killdeer Plains Wildlife Area controlled hunts. Hunters who harvest a deer in Wyandot County during the remaining deer hunting season, which closes on Sunday, February 7, 2021, will be contacted to obtain disease samples by Division of Wildlife staff.

The Division of Wildlife has conducted routine surveillance for CWD since 2002, testing more than 25,000 deer without finding a CWD positive deer in the wild herd. CWD has previously been detected at captive deer breeding facilities in Ohio. Find more information about Ohio’s CWD surveillance at wildohio.gov.

CWD has been detected in 26 states and four Canadian provinces. The disease was first discovered in the 1960s in the western U.S. More information about this disease is available at cwd-info.org.

Hunters should take precautions when handling and processing any harvested deer. Hunters may have a harvested deer tested at the Ohio Department of Agriculture’s Animal Disease Diagnostic Laboratory for a fee. Call (614) 728-6220 for more information.

The mission of the Division of Wildlife is to conserve and improve fish and wildlife resources and their habitats for sustainable use and appreciation by all. Visit wildohio.gov to find out more.

ODNR ensures a balance between wise use and protection of our natural resources for the benefit of all. Visit the ODNR website at ohiodnr.gov.


Chronic Wasting Disease Detected on Wayne County Farm

May 15, 2020 | Animal Health

REYNOLDSBURG, Ohio (May 15, 2020) – Chronic Wasting Disease (CWD) has been detected at a farm in Wayne County. CWD is a degenerative brain disease that affects elk, mule deer and white-tailed deer. Investigators with the Ohio Department of Agriculture (ODA) detected CWD in a doe in the herd. 

ODA is conducting an epidemiological investigation on the farm and developing a herd plan. ODA has applied for an indemnity plan with the United States Department of Agriculture for depopulation of the herd. This is necessary in order to stop the transmission and spread of CWD. Once approved, ODA officials will depopulate the affected herd.

CWD has occurred in Ohio in the past but has been eradicated through depopulation. It has never been found in Ohio’s wild deer herd population. 

If you have questions or concerns regarding CWD, please contact the Division of Animal Health at 614-728-6220 or by email, animal@agri.ohio.gov.


SATURDAY, MAY 16, 2020 
Ohio Chronic Wasting Disease Detected on Wayne County Farm
A captive white-tailed deer breeding facility in Holmes County was confirmed CWD-positive in January 2018 and depopulated in February 2018. Two of the 93 deer euthanized were CWD-positive as well. A disease surveillance area (DSA) has been established around the facility and will remain in effect for at least three years.


Ohio Licenses Issued Captive Whitetail Deer............................335


SATURDAY, FEBRUARY 02, 2019

Ohio Chronic Wasting Disease CWD TSE PRION FEBRUARY 2019 Newsletter Update


TUESDAY, DECEMBER 04, 2018 

Ohio Changes in CWD Sample Submission for IHC Testing, Ohio is considered free of CWD?


THURSDAY, JANUARY 25, 2018 

Ohio Chronic Wasting Disease CWD TSE Prion aka mad deer update 2016-2017 SEASON SUMMARY


January 14, 2018

Ohio ODA confirms CWD TSE Prion in more captive deer




snip...see;


SUNDAY, DECEMBER 03, 2017 

Ohio Chronic Wasting Disease Update Through November 2017


WEDNESDAY, NOVEMBER 15, 2017 

Ohio ODNR Continues Plan to Monitor Ohio’s Deer Herd for Chronic Wasting Disease or do they?


WEDNESDAY, AUGUST 16, 2017

OHIO Chronic Wasting Disease CWD TSE Prion UPDATE?


Ohio Deer Hunting Season 2017-2018 Today, the deer population in Ohio exceeds 750,000.


see map;



A captive white-tailed deer breeding facility in Holmes County was confirmed CWD-positive in January 2018 and depopulated in February 2018. Two of the 93 deer euthanized were CWD-positive as well. A disease surveillance area (DSA) has been established around the facility and will remain in effect for at least three years.


    Disease Surveillance Area (DSA) Changes
    In 2015, the ODNR Division of Wildlife declared a 10-township area in Holmes (all or portions of Ripley, Prairie, Salt Creek, Monroe, Hardy, Berlin, Killbuck, Mechanic, and Richland townships) and Wayne (Franklin and Clinton townships) counties a Disease Surveillance Area (DSA.) The area was formally declared DSA 2015-01 and was to exist for a minimum of three years. Effective July 31, 2018, that designation and all rules associated with it have expired. CWD was not detected in any of the approximately 2,000 wild deer tested that were harvested in the area over a 4-year period. 

    In response to a captive cervid facility testing positive for CWD in January 2018 in eastern Holmes County, a new DSA 2018-01 has been established. All rules associated with DSA 2018-01 are effective beginning August 1st, 2018. These rules include the following: 

    • Requires hunters to bring deer carcasses harvested within the DSA 2018-01 boundaries to an ODNR Division of Wildlife inspection station for sampling during the deer-gun and deer muzzleloader seasons;
    • Prohibits the placement of or use of salt, mineral supplement, grain, fruit, vegetables, or other feed to attract or feed deer within the DSA boundaries;
    • Prohibits hunting of deer by the aid of salt, mineral supplement, grain, fruit, vegetables, or other feed within the DSA boundaries; and
    • Prohibits the removal of a deer carcass killed by a motor vehicle within the DSA 2018-01 boundaries unless the carcass complies with deer carcass restrictions.


    Disease Surveillance Area 2018
     
    Click to enlarge


    Normal agricultural activities including feeding of domestic animals as well as hunting deer over food plots, naturally occurring or cultivated plants and agriculture crops are not prohibited. 

    Hunters harvesting deer during Ohio’s gun seasons (7-day traditional, 2-day bonus, and 4-day muzzleloader) within the DSA are required to deliver their deer to a carcass inspection station. Hunters are NOT required to present their deer for testing during the 2-day youth gun season. Two locations have been designated as Carcass Inspection Stations for the deer-gun seasons and the deer muzzleloader season. Both locations will be open and staffed from 10 a.m. to 8 p.m. during the deer-gun and deer muzzleloader seasons. 

    • Sugarcreek Village Hall (Tuscarawas County), 410 South Broadway Street, Sugarcreek, OH 44681
    • Walnut Creek Township Garage (Holmes County), 2490 Township Road 414, Dundee, OH 44624

    Hunters will be asked to provide their 18-digit confirmation number from the game check process as well as the location where the deer was killed. Tissue samples will be taken and tested for CWD. Samples can be taken from either just the head or complete carcass. Hunters that harvest a deer and wish to have it mounted must still bring their deer to an inspection station. Samples will not be taken at the time, but staff will collect additional information, so samples can be collected later. 

    Although CWD has not been detected in the wild deer herd, hunters who plan to hunt in DSA 2018-01 are encouraged to consider having their deer processed commercially to ensure high-risk carcass parts are disposed of properly. Hunters who plan to process their deer are strongly encouraged to double-bag all high-risk carcass parts and set them with household trash for pickup. There is no strong evidence that CWD affects humans; however, hunters can take some common-sense precautions, such as not harvesting deer that appear sick or otherwise abnormal and wearing rubber gloves while field dressing and processing deer. 

    White-tailed Deer Harvested in Ohio
    Irresponsible dumping of carcasses can spread disease. Hunters who process their white-tailed deer at home should properly dispose of the hide, brain and spinal cord, eyes, spleen, tonsils, bones, and head by double-bagging these parts and set them with the trash for disposal at a municipal landfill. It is unlikely that hunters would increase CWD transmission by field dressing and leaving the entrails and internal organs in the field. 

    Anyone who sees deer that appear to be sick or are displaying abnormal behavior should immediately report the occurrence to the ODNR Division of Wildlife. The person reporting the animal should describe the location of the animal, its symptoms, and behavior. Hunters should not kill or handle a deer that they believe is sick. 



    Chronic Wasting Disease Update

    Dr. Jeff Hayes, MS, DVM, ADDL Pathology Section Head

    Through November 2017, the ADDL has performed immunohistochemistry (IHC) to detect the prion agent associated with Chronic Wasting Disease (CWD) in tissues from 1,585 captive deer and from 411 wild deer this year. The majority of the wild deer were submitted by the Ohio Division of Wildlife. To date this has included the examination of 7,100 tissues. No suspect or positive animals have been detected among all deer tested in 2017, and none have been detected in Ohio since two premises were identified as having CWD-infected captive white-tailed deer in late 2014 and early 2015.


    IT would be great if such a detailed assessment of Chronic Wasting Disease CWD TSE Prion in CAPTIVE FARMS in Ohio were available...terry

    WEDNESDAY, AUGUST 05, 2015

    Ohio confirms to me Chronic Wasting Disease 

    CWD Spreads 19 confirmed cases to date Just got off the phone with Christy Clevenger of Ohio

    Ohio Department of Agriculture March 2012 – Present (3 years 6 months) Reynoldsburg, Ohio CWD program

    Ms. Clevenger confirmed, to date, from the Yoder debacle, 1 confirmed case of CWD from the Hunting Preserve, 2 confirmed cases from the Breeding Farm, and 16 confirmed cases of CWD from the Breeder Depopulation, with a total to date of 19 cases of CWD in Ohio...with sad regards, Terry


    FRIDAY, OCTOBER 23, 2015

    Ohio Wildlife Council Passes Rule to Help Monitor CWD From: Terry S. Singeltary Sr.

    Sent: Friday, October 23, 2015 4:39 PM



    Subject: Ohio Wildlife Council Passes Rule to Help Monitor CWD


    MONDAY, AUGUST 24, 2015 

    Ohio wildlife officials ramp up fight against fatal deer brain disease after 17 more positive tests CWD


    Thursday, April 02, 2015

    OHIO CONFIRMS SECOND POSTIVE CHRONIC WASTING DISEASE CWD on Yoder's properties near Millersburg


    Wednesday, February 11, 2015

    World Class Whitetails quarantined CWD deer Daniel M. Yoder charged with two counts of tampering with evidence


    Thursday, October 23, 2014 

    *** FIRST CASE OF CHRONIC WASTING DISEASE CONFIRMED IN OHIO ON PRIVATE PRESERVE 


    Monday, June 11, 2012

    *** OHIO Captive deer escapees and non-reporting ***


    FRIDAY, MARCH 16, 2012 

    OHIO TURNS OVER CERVID GAME FARMS (and CWD risk) TO DEPARTMENT OF AGRICULTURE, GOD HELP THEM


    Atypical Nor-98 Scrapie Ohio 2010

    Of the five Nor98-like scrapie cases, four were RSSS cases that originated from flocks in Ohio, Pennsylvania, Oregon, and Idaho and one was a field case form Maine. 



    OHIO 13 Scrapie Outbreaks, seem Map of Scrapie Outbreaks USA 1947 to 1977


    Thursday, July 14, 2011

    Valley Farm Meats (DBA Strasburg Provision, Inc) Issues Precautionary Recall for Beef Products Due to Possible Contamination with Prohibited Materials SRM

    Ohio Department of Agriculture and Ohio Department of Health


    TAHC Chapter 40, Chronic Wasting Disease Terry Singeltary Comment Submission

    ***> 1st and foremost your biggest problem is 'VOLUNTARY'! AS with the BSE 589.2001 FEED REGULATIONS, especially since it is still voluntary with cervid, knowing full well that cwd and scrapie will transmit to pigs by oral route. VOLUNTARY DOES NOT WORK! all animal products should be banned and be made mandatory, and the herd certification program should be mandatory, or you don't move cervid. IF THE CWD HERD CERTIFICATION IS NOT MANDATORY, it will be another colossal tse prion failure from the start.

    ***> 2nd USA should declare a Declaration of Extraordinary Emergency due to CWD, and all exports of cervid and cervid products must be stopped internationally, and there should be a ban of interstate movement of cervid, until a live cwd test is available.

    ***> 3rd Captive Farmed cervid ESCAPEES should be made mandatory to report immediately, and strict regulations for those suspect cwd deer that just happen to disappear. IF a cervid escapes and is not found, that farm should be indefinitely shut down, all movement, until aid MIA cervid is found, and if not ever found, that farm shut down permanently.

    ***> 4th Captive Farmed Cervid, INDEMNITY, NO MORE Federal indemnity program, or what i call, ENTITLEMENT PROGRAM for game farm industry. NO MORE BAIL OUTS FROM TAX PAYERS. if the captive industry can't buy insurance to protect not only themselves, but also their customers, and especially the STATE, from Chronic Wasting Disease CWD TSE Prion or what some call mad deer disease and harm therefrom, IF they can't afford to buy that insurance that will cover all of it, then they DO NOT GET A PERMIT to have a game farm for anything. This CWD TSE Prion can/could/has caused property values to fall from some reports in some places. roll the dice, how much is a state willing to lose?

    ***> 5th QUARANTINE OF ALL FARMED CAPTIVE, BREEDERS, URINE, ANTLER, VELVET, SPERM, OR ANY FACILITY, AND THEIR PRODUCTS, that has been confirmed to have Chronic Wasting Disease CWD TSE Prion, the QUARANTINE should be for 21 years due to science showing what scrapie can do. 5 years is NOT near long enough. see; Infectious agent of sheep scrapie may persist in the environment for at least 16 to 21 years.

    ***> 6th America BSE 589.2001 FEED REGULATIONS CWD TSE Prion

    ***> 7TH TRUCKING TRANSPORTING CERVID CHRONIC WASTING DISEASE TSE PRION VIOLATING THE LACEY ACT

    ***> 8TH ALL CAPTIVE FARMING CERVID OPERATIONS MUST BE INSURED TO PAY FOR ANY CLEAN UP OF CWD AND QUARANTINE THERE FROM FOR THE STATE, NO MORE ENTITLEMENT PROGRAM FOR CERVID GAME FARMING PAY TO PLAY FOR CWD TSE PRION OFF THE TAX PAYERS BACK.

    ***> 9TH ANY STATE WITH DOCUMENTED CWD, INTERSTATE, NATIONAL, AND INTERNATIONAL MOVEMENT OF ALL CERVID, AND ALL CERVID PRODUCTS MUST BE HALTED!

    ***> 10TH BAN THE SALE OF STRAW BRED BUCKS AND ALL CERVID SEMEN AND URINE PRODUCTS

    ***> 11th ALL CAPTIVE FARMED CERVID AND THEIR PRODUCTS MUST BE CWD TSE PRION TESTED ANNUALLY AND BEFORE SALE FOR CWD TSE PRION

    SEE FULL SCIENCE REFERENCES AND REASONINGS

    Control of Chronic Wasting Disease OMB Control Number: 0579-0189 APHIS-2021-0004 Singeltary Submission



    Docket No. APHIS-2018-0011 Chronic Wasting Disease Herd Certification



    CHRONIC WASTING DISEASE CWD TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TSE PRION

    ***> cattle, pigs, sheep, cwd, tse, prion, oh my! 

    ***> In contrast, cattle are highly susceptible to white-tailed deer CWD and mule deer CWD in experimental conditions but no natural CWD infections in cattle have been reported (Sigurdson, 2008; Hamir et al., 2006). 

    Sheep and cattle may be exposed to CWD via common grazing areas with affected deer but so far, appear to be poorly susceptible to mule deer CWD (Sigurdson, 2008). In contrast, cattle are highly susceptible to white-tailed deer CWD and mule deer CWD in experimental conditions but no natural CWD infections in cattle have been reported (Sigurdson, 2008; Hamir et al., 2006). It is not known how susceptible humans are to CWD but given that the prion can be present in muscle, it is likely that humans have been exposed to the agent via consumption of venison (Sigurdson, 2008). Initial experimental research suggests that human susceptibility to CWD is low and there may be a robust species barrier for CWD transmission to humans (Sigurdson, 2008), however the risk appetite for a public health threat may still find this level unacceptable. 



    MONDAY, NOVEMBER 16, 2020 

    North America coyotes or pumas can serve as a vehicle for prions contributing to the spread of the infectious agent in the environment 


    Published: 06 September 2021

    Chronic wasting disease: a cervid prion infection looming to spillover

    Alicia Otero, Camilo Duque Velásquez, Judd Aiken & Debbie McKenzie 

    Veterinary Research volume 52, Article number: 115 (2021) 


    Voluntary Chronic Wasting Disease Herd Certification Program Annual Update, FY2020

    Last Modified: Feb 9, 2021

    U.S. Department of Agriculture

    Animal and Plant Health Inspection Service (APHIS) Veterinary Services

    Annual Update from the Cervid Health Team

    Voluntary Chronic Wasting Disease Herd Certification Program (HCP)

    The APHIS National CWD Herd Certification Program (HCP) was implemented in 2014. It is a voluntary Federal-State-industry cooperative program administered by APHIS and implemented by participating States. The program provides uniform national herd certification standards that minimize the risk of spreading CWD in farmed cervid populations. Participating States and herd owners must comply with requirements for animal identification, fencing, recordkeeping, inspections/inventories, as well as animal mortality testing and response to any CWD-exposed, suspect, and positive herds. APHIS monitors the Approved State HCPs to ensure consistency with Federal standards through annual reporting by the States.

    With each year of successful surveillance, herds participating in the HCP will advance in status until reaching five years with no evidence of CWD, at which time herds are certified as being low risk for CWD. Only farmed cervids from enrolled herds certified as low risk for CWD may move interstate. FY 2020 marks the eighth year that Approved States have submitted their CWD HCP annual reports to APHIS.

    The current Cervid Health Program staff officers are as follows: Dr. Mark Lyons, Dr. Jennifer Siembieda, and Dr. Tracy Nichols

    Voluntary Herd Certification Participation Summary

    Currently, 28 States participate in the voluntary CWD Herd Certification Program encompassing 2,145 enrolled herds, of which, 1,723 had the certified status in the program.

    1,616 enrolled deer herds, of which, 1,297 were certified

    371 enrolled elk herds, of which, 328 were certified

    147 enrolled mixed species herds, of which, 98 were certified

    CWD in Farmed Cervids Summary of CW Detections

    There were 22 newly identified CWD positive herds in FY20

    13 of these herds were not participants in the Federal HCP

    2 herds were considered enrolled in the HCP

    7 herds were certified in the HCP

    Half of the herds were located within 20 miles of identified CWD in the wild, half were not CWD Herds by State

    Pennsylvania: Eight new CWD positive herds

    Breeding herd of 33 WTD, HCP certified, depopulated with Federal indemnity

    Breeding herd of 6 WTD, not in HCP, depopulated with Federal indemnity

    Breeding herd of 15 WTD, not in HCP, depopulated by owner\

    Hunt preserve of 58 WTD, not in HCP, populated and under quarantine

    Breeding herd of 75 WTD, not in HCP, populated and under quarantine

    Breeding herd of WTD, not in HCP, populated and under quarantine

    Breeding herd of 90 WTD, not in HCP, populated and under quarantine

    Breeding herd of 4 WTD, not in HCP, populated and under quarantine

    Iowa: Two new CWD positive herds

    Breeding herd of 23 WTD, HCP certified, depopulated with Federal indemnity

    Breeding herd of 13 WTD, HCP certified, depopulated with Federal indemnity

    Minnesota: Two new CWD positive herds

    Breeding herd of 3 WTD, enrolled in HCP, not certified, depopulated by owner

    Breeding herd of 6 WTD, enrolled in HCP, not certified, depopulated with Federal indemnity

    Colorado: Two new CWD positive herds

    Breeding herd/hunt preserve of 9 elk, HCP certified, depopulated by owner

    Breeding herd of 8 elk, HCP certified, populated and under quarantine

    Utah: Two new CWD positive herds

    Breeding herd of 465 elk, not in HCP, partial depopulation with Federal indemnity- removed purchased animals, populated-quarantine

    Breeding herd of 103 elk, not in HCP, partial depopulation with Federal indemnity- removed purchased animals, populated-quarantine

    Michigan: One new CWD positive herd

    Hunt preserve of >600 WTD, not in HCP, populated and under quarantine

    Montana: One new CWD positive herd

    Breeding herd of 3 elk, not in HCP, populated and under quarantine

    Texas: one new CWD positive herd

    Breeding herd of 59 WTD, not in HCP, depopulated with Federal indemnity

    Kansas: One new CWD positive herd

    Breeding herd of 20 elk, HCP certified, depopulated with Federal indemnity

    Ohio: Eight new CWD positive herd

    Breeding herd of 138 WTD, HCP certified, depopulated with Federal indemnity

    Research

    Whole genome study investigating the association of genetics with CWD susceptibility has been published.

    Blinded validation of the genetic predicative model is almost complete

    A standardized protocol has been developed, in partnership with ARS, USGS, University of WI, and NIH for tissue sample testing using RT-QuIC

    A study is starting shortly to determine the sensitivity and specify of RT-QuIC utilizing the standardized protocol

    snip...

    Voluntary Chronic Wasting Disease Herd Certification Program Annual Update, FY2020


    SUNDAY, OCTOBER 24, 2021 

    Voluntary Chronic Wasting Disease Herd Certification Program Annual Update, FY2020


    Cervids: CWD Voluntary Herd Certification Program

    Last Modified: Jun 29, 2021


    CWD status of captive herds


    SATURDAY, OCTOBER 23, 2021 

    USDA APHIS Farmed Cervid Chronic Wasting Disease Management and Response Activities 2021 and other Cooperative Agreements 2021 Spending Plans


    MONDAY, OCTOBER 04, 2021 

    APHIS Provides $5.7 Million in Funding to Control and Prevent Chronic Wasting Disease


    WEDNESDAY, OCTOBER 13, 2021 

    Continuing Enhanced National Surveillance for Prion Diseases in the U.S.

    The estimated total program funding for this effort is $17,500,000.

    THE tse prion aka mad cow type disease is not your normal pathogen. 

    The TSE prion disease survives ashing to 600 degrees celsius, that’s around 1112 degrees farenheit. 

    you cannot cook the TSE prion disease out of meat. 

    you can take the ash and mix it with saline and inject that ash into a mouse, and the mouse will go down with TSE. 

    Prion Infected Meat-and-Bone Meal Is Still Infectious after Biodiesel Production as well. 

    the TSE prion agent also survives Simulated Wastewater Treatment Processes. 

    IN fact, you should also know that the TSE Prion agent will survive in the environment for years, if not decades. 

    you can bury it and it will not go away. 

    The TSE agent is capable of infected your water table i.e. Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. 

    it’s not your ordinary pathogen you can just cook it out and be done with. 

    ***> that’s what’s so worrisome about Iatrogenic mode of transmission, a simple autoclave will not kill this TSE prion agent.

    1: J Neurol Neurosurg Psychiatry 1994 Jun;57(6):757-8 

    ***> Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. 

    Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. 

    Laboratory of Central Nervous System Studies, National Institute of 

    Neurological Disorders and Stroke, National Institutes of Health, 

    Bethesda, MD 20892. 

    Stereotactic multicontact electrodes used to probe the cerebral cortex of a middle aged woman with progressive dementia were previously implicated in the accidental transmission of Creutzfeldt-Jakob disease (CJD) to two younger patients. The diagnoses of CJD have been confirmed for all three cases. More than two years after their last use in humans, after three cleanings and repeated sterilisation in ethanol and formaldehyde vapour, the electrodes were implanted in the cortex of a chimpanzee. Eighteen months later the animal became ill with CJD. This finding serves to re-emphasise the potential danger posed by reuse of instruments contaminated with the agents of spongiform encephalopathies, even after scrupulous attempts to clean them. 

    PMID: 8006664 [PubMed - indexed for MEDLINE] 


    New studies on the heat resistance of hamster-adapted scrapie agent: Threshold survival after ashing at 600°C suggests an inorganic template of replication 


    Prion Infected Meat-and-Bone Meal Is Still Infectious after Biodiesel Production 


    MONDAY, APRIL 19, 2021

    Evaluation of the application for new alternative biodiesel production process for rendered fat including Category 1 animal by-products (BDI-RepCat® process, AT) ???


    Detection of protease-resistant cervid prion protein in water from a CWD-endemic area 


    A Quantitative Assessment of the Amount of Prion Diverted to Category 1 Materials and Wastewater During Processing 


    Rapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone meals 


    THURSDAY, FEBRUARY 28, 2019 

    BSE infectivity survives burial for five years with only limited spread


    WEDNESDAY, DECEMBER 04, 2013 

    Chronic Wasting Disease CWD and Land Value concerns? 


    5 or 6 years quarantine is NOT LONG ENOUGH FOR CWD TSE PRION !!!

    QUARANTINE NEEDS TO BE 21 YEARS FOR CWD TSE PRION !

    FRIDAY, APRIL 30, 2021 

    Should Property Evaluations Contain Scrapie, CWD, TSE PRION Environmental Contamination of the land?

    ***> Confidential!!!!

    ***> As early as 1992-3 there had been long studies conducted on small pastures containing scrapie infected sheep at the sheep research station associated with the Neuropathogenesis Unit in Edinburgh, Scotland. Whether these are documented...I don't know. But personal recounts both heard and recorded in a daily journal indicate that leaving the pastures free and replacing the topsoil completely at least 2 feet of thickness each year for SEVEN years....and then when very clean (proven scrapie free) sheep were placed on these small pastures.... the new sheep also broke out with scrapie and passed it to offspring. I am not sure that TSE contaminated ground could ever be free of the agent!! A very frightening revelation!!!

    ---end personal email---end...tss


    and so it seems...

    Scrapie Agent (Strain 263K) Can Transmit Disease via the Oral Route after Persistence in Soil over Years

    Published: May 9, 2007

    snip...

    Our results showed that 263K scrapie agent can persist in soil at least over 29 months. Strikingly, not only the contaminated soil itself retained high levels of infectivity, as evidenced by oral administration to Syrian hamsters, but also feeding of aqueous soil extracts was able to induce disease in the reporter animals. We could also demonstrate that PrPSc in soil, extracted after 21 months, provides a catalytically active seed in the protein misfolding cyclic amplification (PMCA) reaction. PMCA opens therefore a perspective for considerably improving the detectability of prions in soil samples from the field.

    snip...


    ***> This is very likely to have parallels with control efforts for CWD in cervids. <***

    Paper

    Rapid recontamination of a farm building occurs after attempted prion removal

    Kevin Christopher Gough BSc (Hons), PhD Claire Alison Baker BSc (Hons) Steve Hawkins MIBiol Hugh Simmons BVSc, MRCVS, MBA, MA Timm Konold DrMedVet, PhD, MRCVS … See all authors 

    First published: 19 January 2019 https://doi.org/10.1136/vr.105054

    Abstract

    The transmissible spongiform encephalopathy scrapie of sheep/goats and chronic wasting disease of cervids are associated with environmental reservoirs of infectivity. Preventing environmental prions acting as a source of infectivity to healthy animals is of major concern to farms that have had outbreaks of scrapie and also to the health management of wild and farmed cervids. Here, an efficient scrapie decontamination protocol was applied to a farm with high levels of environmental contamination with the scrapie agent. Post‐decontamination, no prion material was detected within samples taken from the farm buildings as determined using a sensitive in vitro replication assay (sPMCA). A bioassay consisting of 25 newborn lambs of highly susceptible prion protein genotype VRQ/VRQ introduced into this decontaminated barn was carried out in addition to sampling and analysis of dust samples that were collected during the bioassay. Twenty‐four of the animals examined by immunohistochemical analysis of lymphatic tissues were scrapie‐positive during the bioassay, samples of dust collected within the barn were positive by month 3. The data illustrates the difficulty in decontaminating farm buildings from scrapie, and demonstrates the likely contribution of farm dust to the recontamination of these environments to levels that are capable of causing disease.

    snip...

    This study clearly demonstrates the difficulty in removing scrapie infectivity from the farm environment. Practical and effective prion decontamination methods are still urgently required for decontamination of scrapie infectivity from farms that have had cases of scrapie and this is particularly relevant for scrapiepositive goatherds, which currently have limited genetic resistance to scrapie within commercial breeds.24 This is very likely to have parallels with control efforts for CWD in cervids.


    ***>This is very likely to have parallels with control efforts for CWD in cervids.


    ***> Infectious agent of sheep scrapie may persist in the environment for at least 16 years

    ***> Nine of these recurrences occurred 14–21 years after culling, apparently as the result of environmental contamination, but outside entry could not always be absolutely excluded. 

    JOURNAL OF GENERAL VIROLOGY Volume 87, Issue 12

    Infectious agent of sheep scrapie may persist in the environment for at least 16 years Free

    Gudmundur Georgsson1, Sigurdur Sigurdarson2, Paul Brown3


    Front. Vet. Sci., 14 September 2015 | https://doi.org/10.3389/fvets.2015.00032

    Objects in contact with classical scrapie sheep act as a reservoir for scrapie transmission

    imageTimm Konold1*, imageStephen A. C. Hawkins2, imageLisa C. Thurston3, imageBen C. Maddison4, imageKevin C. Gough5, imageAnthony Duarte1 and imageHugh A. Simmons1

    1Animal Sciences Unit, Animal and Plant Health Agency Weybridge, Addlestone, UK

    2Pathology Department, Animal and Plant Health Agency Weybridge, Addlestone, UK

    3Surveillance and Laboratory Services, Animal and Plant Health Agency Penrith, Penrith, UK

    4ADAS UK, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UK

    5School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UK

    Classical scrapie is an environmentally transmissible prion disease of sheep and goats. Prions can persist and remain potentially infectious in the environment for many years and thus pose a risk of infecting animals after re-stocking. In vitro studies using serial protein misfolding cyclic amplification (sPMCA) have suggested that objects on a scrapie-affected sheep farm could contribute to disease transmission. This in vivo study aimed to determine the role of field furniture (water troughs, feeding troughs, fencing, and other objects that sheep may rub against) used by a scrapie-infected sheep flock as a vector for disease transmission to scrapie-free lambs with the prion protein genotype VRQ/VRQ, which is associated with high susceptibility to classical scrapie. When the field furniture was placed in clean accommodation, sheep became infected when exposed to either a water trough (four out of five) or to objects used for rubbing (four out of seven). This field furniture had been used by the scrapie-infected flock 8 weeks earlier and had previously been shown to harbor scrapie prions by sPMCA. Sheep also became infected (20 out of 23) through exposure to contaminated field furniture placed within pasture not used by scrapie-infected sheep for 40 months, even though swabs from this furniture tested negative by PMCA. This infection rate decreased (1 out of 12) on the same paddock after replacement with clean field furniture. Twelve grazing sheep exposed to field furniture not in contact with scrapie-infected sheep for 18 months remained scrapie free. The findings of this study highlight the role of field furniture used by scrapie-infected sheep to act as a reservoir for disease re-introduction although infectivity declines considerably if the field furniture has not been in contact with scrapie-infected sheep for several months. PMCA may not be as sensitive as VRQ/VRQ sheep to test for environmental contamination.

    snip...

    Discussion 

    Classical scrapie is an environmentally transmissible disease because it has been reported in naïve, supposedly previously unexposed sheep placed in pastures formerly occupied by scrapie-infected sheep (4, 19, 20). 

    Although the vector for disease transmission is not known, soil is likely to be an important reservoir for prions (2) where – based on studies in rodents – prions can adhere to minerals as a biologically active form (21) and remain infectious for more than 2 years (22). 

    Similarly, chronic wasting disease (CWD) has re-occurred in mule deer housed in paddocks used by infected deer 2 years earlier, which was assumed to be through foraging and soil consumption (23). 

    Our study suggested that the risk of acquiring scrapie infection was greater through exposure to contaminated wooden, plastic, and metal surfaces via water or food troughs, fencing, and hurdles than through grazing. 

    Drinking from a water trough used by the scrapie flock was sufficient to cause infection in sheep in a clean building. 

    Exposure to fences and other objects used for rubbing also led to infection, which supported the hypothesis that skin may be a vector for disease transmission (9). 

    The risk of these objects to cause infection was further demonstrated when 87% of 23 sheep presented with PrPSc in lymphoid tissue after grazing on one of the paddocks, which contained metal hurdles, a metal lamb creep and a water trough in contact with the scrapie flock up to 8 weeks earlier, whereas no infection had been demonstrated previously in sheep grazing on this paddock, when equipped with new fencing and field furniture. 

    When the contaminated furniture and fencing were removed, the infection rate dropped significantly to 8% of 12 sheep, with soil of the paddock as the most likely source of infection caused by shedding of prions from the scrapie-infected sheep in this paddock up to a week earlier. 

    This study also indicated that the level of contamination of field furniture sufficient to cause infection was dependent on two factors: stage of incubation period and time of last use by scrapie-infected sheep. 

    Drinking from a water trough that had been used by scrapie sheep in the predominantly pre-clinical phase did not appear to cause infection, whereas infection was shown in sheep drinking from the water trough used by scrapie sheep in the later stage of the disease. 

    It is possible that contamination occurred through shedding of prions in saliva, which may have contaminated the surface of the water trough and subsequently the water when it was refilled. 

    Contamination appeared to be sufficient to cause infection only if the trough was in contact with sheep that included clinical cases. 

    Indeed, there is an increased risk of bodily fluid infectivity with disease progression in scrapie (24) and CWD (25) based on PrPSc detection by sPMCA. 

    Although ultraviolet light and heat under natural conditions do not inactivate prions (26), furniture in contact with the scrapie flock, which was assumed to be sufficiently contaminated to cause infection, did not act as vector for disease if not used for 18 months, which suggest that the weathering process alone was sufficient to inactivate prions. 

    PrPSc detection by sPMCA is increasingly used as a surrogate for infectivity measurements by bioassay in sheep or mice. 

    In this reported study, however, the levels of PrPSc present in the environment were below the limit of detection of the sPMCA method, yet were still sufficient to cause infection of in-contact animals. 

    In the present study, the outdoor objects were removed from the infected flock 8 weeks prior to sampling and were positive by sPMCA at very low levels (2 out of 37 reactions). 

    As this sPMCA assay also yielded 2 positive reactions out of 139 in samples from the scrapie-free farm, the sPMCA assay could not detect PrPSc on any of the objects above the background of the assay. 

    False positive reactions with sPMCA at a low frequency associated with de novo formation of infectious prions have been reported (27, 28). 

    This is in contrast to our previous study where we demonstrated that outdoor objects that had been in contact with the scrapie-infected flock up to 20 days prior to sampling harbored PrPSc that was detectable by sPMCA analysis [4 out of 15 reactions (12)] and was significantly more positive by the assay compared to analogous samples from the scrapie-free farm. 

    This discrepancy could be due to the use of a different sPMCA substrate between the studies that may alter the efficiency of amplification of the environmental PrPSc. 

    In addition, the present study had a longer timeframe between the objects being in contact with the infected flock and sampling, which may affect the levels of extractable PrPSc. 

    Alternatively, there may be potentially patchy contamination of this furniture with PrPSc, which may have been missed by swabbing. 

    The failure of sPMCA to detect CWD-associated PrP in saliva from clinically affected deer despite confirmation of infectivity in saliva-inoculated transgenic mice was associated with as yet unidentified inhibitors in saliva (29), and it is possible that the sensitivity of sPMCA is affected by other substances in the tested material. 

    In addition, sampling of amplifiable PrPSc and subsequent detection by sPMCA may be more difficult from furniture exposed to weather, which is supported by the observation that PrPSc was detected by sPMCA more frequently in indoor than outdoor furniture (12). 

    A recent experimental study has demonstrated that repeated cycles of drying and wetting of prion-contaminated soil, equivalent to what is expected under natural weathering conditions, could reduce PMCA amplification efficiency and extend the incubation period in hamsters inoculated with soil samples (30). 

    This seems to apply also to this study even though the reduction in infectivity was more dramatic in the sPMCA assays than in the sheep model. 

    Sheep were not kept until clinical end-point, which would have enabled us to compare incubation periods, but the lack of infection in sheep exposed to furniture that had not been in contact with scrapie sheep for a longer time period supports the hypothesis that prion degradation and subsequent loss of infectivity occurs even under natural conditions. 

    In conclusion, the results in the current study indicate that removal of furniture that had been in contact with scrapie-infected animals should be recommended, particularly since cleaning and decontamination may not effectively remove scrapie infectivity (31), even though infectivity declines considerably if the pasture and the field furniture have not been in contact with scrapie-infected sheep for several months. As sPMCA failed to detect PrPSc in furniture that was subjected to weathering, even though exposure led to infection in sheep, this method may not always be reliable in predicting the risk of scrapie infection through environmental contamination. 

    These results suggest that the VRQ/VRQ sheep model may be more sensitive than sPMCA for the detection of environmentally associated scrapie, and suggest that extremely low levels of scrapie contamination are able to cause infection in susceptible sheep genotypes. 

    Keywords: classical scrapie, prion, transmissible spongiform encephalopathy, sheep, field furniture, reservoir, serial protein misfolding cyclic amplification 

    ***> CONGRESSIONAL ABSTRACTS PRION CONFERENCE 2018

    P69 Experimental transmission of CWD from white-tailed deer to co-housed reindeer 

    Mitchell G (1), Walther I (1), Staskevicius A (1), Soutyrine A (1), Balachandran A (1) 

    (1) National & OIE Reference Laboratory for Scrapie and CWD, Canadian Food Inspection Agency, Ottawa, Ontario, Canada. 

    Chronic wasting disease (CWD) continues to be detected in wild and farmed cervid populations of North America, affecting predominantly white-tailed deer, mule deer and elk. Extensive herds of wild caribou exist in northern regions of Canada, although surveillance has not detected the presence of CWD in this population. Oral experimental transmission has demonstrated that reindeer, a species closely related to caribou, are susceptible to CWD. Recently, CWD was detected for the first time in Europe, in wild Norwegian reindeer, advancing the possibility that caribou in North America could also become infected. Given the potential overlap in habitat between wild CWD-infected cervids and wild caribou herds in Canada, we sought to investigate the horizontal transmissibility of CWD from white-tailed deer to reindeer. 

    Two white-tailed deer were orally inoculated with a brain homogenate prepared from a farmed Canadian white-tailed deer previously diagnosed with CWD. Two reindeer, with no history of exposure to CWD, were housed in the same enclosure as the white-tailed deer, 3.5 months after the deer were orally inoculated. The white-tailed deer developed clinical signs consistent with CWD beginning at 15.2 and 21 months post-inoculation (mpi), and were euthanized at 18.7 and 23.1 mpi, respectively. Confirmatory testing by immunohistochemistry (IHC) and western blot demonstrated widespread aggregates of pathological prion protein (PrPCWD) in the central nervous system and lymphoid tissues of both inoculated white-tailed deer. Both reindeer were subjected to recto-anal mucosal associated lymphoid tissue (RAMALT) biopsy at 20 months post-exposure (mpe) to the white-tailed deer. The biopsy from one reindeer contained PrPCWD confirmed by IHC. This reindeer displayed only subtle clinical evidence of disease prior to a rapid decline in condition requiring euthanasia at 22.5 mpe. Analysis of tissues from this reindeer by IHC revealed widespread PrPCWD deposition, predominantly in central nervous system and lymphoreticular tissues. Western blot molecular profiles were similar between both orally inoculated white-tailed deer and the CWD positive reindeer. Despite sharing the same enclosure, the other reindeer was RAMALT negative at 20 mpe, and PrPCWD was not detected in brainstem and lymphoid tissues following necropsy at 35 mpe. Sequencing of the prion protein gene from both reindeer revealed differences at several codons, which may have influenced susceptibility to infection. 

    Natural transmission of CWD occurs relatively efficiently amongst cervids, supporting the expanding geographic distribution of disease and the potential for transmission to previously naive populations. The efficient horizontal transmission of CWD from white-tailed deer to reindeer observed here highlights the potential for reindeer to become infected if exposed to other cervids or environments infected with CWD. 

    SOURCE REFERENCE 2018 PRION CONFERENCE ABSTRACT

    Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Location: Virus and Prion Research

    Title: Horizontal transmission of chronic wasting disease in reindeer

    Author

    item MOORE, SARAH - ORISE FELLOW item KUNKLE, ROBERT item WEST GREENLEE, MARY - IOWA STATE UNIVERSITY item Nicholson, Eric item RICHT, JUERGEN item HAMIR, AMIRALI item WATERS, WADE item Greenlee, Justin

    Submitted to: Emerging Infectious Diseases

    Publication Type: Peer Reviewed Journal

    Publication Acceptance Date: 8/29/2016

    Publication Date: 12/1/2016

    Citation: Moore, S., Kunkle, R., Greenlee, M., Nicholson, E., Richt, J., Hamir, A., Waters, W., Greenlee, J. 2016. Horizontal transmission of chronic wasting disease in reindeer. Emerging Infectious Diseases. 22(12):2142-2145. doi:10.3201/eid2212.160635.

    Interpretive Summary: Chronic wasting disease (CWD) is a fatal neurodegenerative disease that occurs in farmed and wild cervids (deer and elk) of North America and was recently diagnosed in a single free-ranging reindeer (Rangifer tarandus tarandus) in Norway. CWD is a transmissible spongiform encephalopathy (TSE) that is caused by infectious proteins called prions that are resistant to various methods of decontamination and environmental degradation. Little is known about the susceptibility of or potential for transmission amongst reindeer. In this experiment, we tested the susceptibility of reindeer to CWD from various sources (elk, mule deer, or white-tailed deer) after intracranial inoculation and tested the potential for infected reindeer to transmit to non-inoculated animals by co-housing or housing in adjacent pens. Reindeer were susceptible to CWD from elk, mule deer, or white-tailed deer sources after experimental inoculation. Most importantly, non-inoculated reindeer that were co-housed with infected reindeer or housed in pens adjacent to infected reindeer but without the potential for nose-to-nose contact also developed evidence of CWD infection. This is a major new finding that may have a great impact on the recently diagnosed case of CWD in the only remaining free-ranging reindeer population in Europe as our findings imply that horizontal transmission to other reindeer within that herd has already occurred. Further, this information will help regulatory and wildlife officials developing plans to reduce or eliminate CWD and cervid farmers that want to ensure that their herd remains CWD-free, but were previously unsure of the potential for reindeer to transmit CWD.

    Technical Abstract: Chronic wasting disease (CWD) is a naturally-occurring, fatal prion disease of cervids. Reindeer (Rangifer tarandus tarandus) are susceptible to CWD following oral challenge, and CWD was recently reported in a free-ranging reindeer of Norway. Potential contact between CWD-affected cervids and Rangifer species that are free-ranging or co-housed on farms presents a potential risk of CWD transmission. The aims of this study were to 1) investigate the transmission of CWD from white-tailed deer (Odocoileus virginianus; CWDwtd), mule deer (Odocoileus hemionus; CWDmd), or elk (Cervus elaphus nelsoni; CWDelk) to reindeer via the intracranial route, and 2) to assess for direct and indirect horizontal transmission to non-inoculated sentinels. Three groups of 5 reindeer fawns were challenged intracranially with CWDwtd, CWDmd, or CWDelk. Two years after challenge of inoculated reindeer, non-inoculated negative control reindeer were introduced into the same pen as the CWDwtd inoculated reindeer (direct contact; n=4) or into a pen adjacent to the CWDmd inoculated reindeer (indirect contact; n=2). Experimentally inoculated reindeer were allowed to develop clinical disease. At death/euthanasia a complete necropsy examination was performed, including immunohistochemical testing of tissues for disease-associated CWD prion protein (PrPcwd). Intracranially challenged reindeer developed clinical disease from 21 months post-inoculation (months PI). PrPcwd was detected in 5 out of 6 sentinel reindeer although only 2 out of 6 developed clinical disease during the study period (< 57 months PI). We have shown that reindeer are susceptible to CWD from various cervid sources and can transmit CWD to naïve reindeer both directly and indirectly.


    Infectivity surviving ashing to 600*C is (in my opinion) degradable but infective. based on Bown & Gajdusek, (1991), landfill and burial may be assumed to have a reduction factor of 98% (i.e. a factor of 50) over 3 years. CJD-infected brain-tissue remained infectious after storing at room-temperature for 22 months (Tateishi et al, 1988). Scrapie agent is known to remain viable after at least 30 months of desiccation (Wilson et al, 1950). and pastures that had been grazed by scrapie-infected sheep still appeared to be contaminated with scrapie agent three years after they were last occupied by sheep (Palsson, 1979).


    Dr. Paul Brown Scrapie Soil Test BSE Inquiry Document


    Using in vitro Prion replication for high sensitive detection of prions and prionlike proteins and for understanding mechanisms of transmission. 

    Claudio Soto Mitchell Center for Alzheimer's diseases and related Brain disorders, Department of Neurology, University of Texas Medical School at Houston. 

    Prion and prion-like proteins are misfolded protein aggregates with the ability to selfpropagate to spread disease between cells, organs and in some cases across individuals. I n T r a n s m i s s i b l e s p o n g i f o r m encephalopathies (TSEs), prions are mostly composed by a misfolded form of the prion protein (PrPSc), which propagates by transmitting its misfolding to the normal prion protein (PrPC). The availability of a procedure to replicate prions in the laboratory may be important to study the mechanism of prion and prion-like spreading and to develop high sensitive detection of small quantities of misfolded proteins in biological fluids, tissues and environmental samples. Protein Misfolding Cyclic Amplification (PMCA) is a simple, fast and efficient methodology to mimic prion replication in the test tube. PMCA is a platform technology that may enable amplification of any prion-like misfolded protein aggregating through a seeding/nucleation process. In TSEs, PMCA is able to detect the equivalent of one single molecule of infectious PrPSc and propagate prions that maintain high infectivity, strain properties and species specificity. Using PMCA we have been able to detect PrPSc in blood and urine of experimentally infected animals and humans affected by vCJD with high sensitivity and specificity. Recently, we have expanded the principles of PMCA to amplify amyloid-beta (Aβ) and alphasynuclein (α-syn) aggregates implicated in Alzheimer's and Parkinson's diseases, respectively. Experiments are ongoing to study the utility of this technology to detect Aβ and α-syn aggregates in samples of CSF and blood from patients affected by these diseases.

    =========================

    ***>>> Recently, we have been using PMCA to study the role of environmental prion contamination on the horizontal spreading of TSEs. These experiments have focused on the study of the interaction of prions with plants and environmentally relevant surfaces. Our results show that plants (both leaves and roots) bind tightly to prions present in brain extracts and excreta (urine and feces) and retain even small quantities of PrPSc for long periods of time. Strikingly, ingestion of prioncontaminated leaves and roots produced disease with a 100% attack rate and an incubation period not substantially longer than feeding animals directly with scrapie brain homogenate. Furthermore, plants can uptake prions from contaminated soil and transport them to different parts of the plant tissue (stem and leaves). Similarly, prions bind tightly to a variety of environmentally relevant surfaces, including stones, wood, metals, plastic, glass, cement, etc. Prion contaminated surfaces efficiently transmit prion disease when these materials were directly injected into the brain of animals and strikingly when the contaminated surfaces were just placed in the animal cage. These findings demonstrate that environmental materials can efficiently bind infectious prions and act as carriers of infectivity, suggesting that they may play an important role in the horizontal transmission of the disease.

    ========================

    Since its invention 13 years ago, PMCA has helped to answer fundamental questions of prion propagation and has broad applications in research areas including the food industry, blood bank safety and human and veterinary disease diagnosis. 

    source reference Prion Conference 2015 abstract book

    Grass Plants Bind, Retain, Uptake, and Transport Infectious Prions

    Sandra Pritzkow,1 Rodrigo Morales,1 Fabio Moda,1,3 Uffaf Khan,1 Glenn C. Telling,2 Edward Hoover,2 and Claudio Soto1, * 1Mitchell Center for Alzheimer’s Disease and Related Brain Disorders, Department of Neurology, University of Texas Medical School at Houston, 6431 Fannin Street, Houston, TX 77030, USA

    2Prion Research Center, Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA

    3Present address: IRCCS Foundation Carlo Besta Neurological Institute, 20133 Milan, Italy *Correspondence: claudio.soto@uth.tmc.edu http://dx.doi.org/10.1016/j.celrep.2015.04.036

    SUMMARY

    Prions are the protein-based infectious agents responsible for prion diseases. Environmental prion contamination has been implicated in disease transmission. Here, we analyzed the binding and retention of infectious prion protein (PrPSc) to plants. Small quantities of PrPSc contained in diluted brain homogenate or in excretory materials (urine and feces) can bind to wheat grass roots and leaves. Wild-type hamsters were efficiently infected by ingestion of prion-contaminated plants. The prion-plant interaction occurs with prions from diverse origins, including chronic wasting disease. Furthermore, leaves contaminated by spraying with a prion-containing preparation retained PrPSc for several weeks in the living plant. Finally, plants can uptake prions from contaminated soil and transport them to aerial parts of the plant (stem and leaves). These findings demonstrate that plants can efficiently bind infectious prions and act as carriers of infectivity, suggesting a possible role of environmental prion contamination in the horizontal transmission of the disease.

    INTRODUCTION

    snip...

    DISCUSSION

    This study shows that plants can efficiently bind prions contained in brain extracts from diverse prion infected animals, including CWD-affected cervids. PrPSc attached to leaves and roots from wheat grass plants remains capable of seeding prion replication in vitro. Surprisingly, the small quantity of PrPSc naturally excreted in urine and feces from sick hamster or cervids was enough to efficiently contaminate plant tissue. Indeed, our results suggest that the majority of excreted PrPSc is efficiently captured by plants’ leaves and roots. Moreover, leaves can be contaminated by spraying them with a prion-containing extract, and PrPSc remains detectable in living plants for as long as the study was performed (several weeks). Remarkably, prion contaminated plants transmit prion disease to animals upon ingestion, producing a 100% attack rate and incubation periods not substantially longer than direct oral administration of sick brain homogenates.

    Finally, an unexpected but exciting result was that plants were able to uptake prions from contaminated soil and transport them to aerial parts of the plant tissue. Although it may seem farfetched that plants can uptake proteins from the soil and transport it to the parts above the ground, there are already published reports of this phenomenon (McLaren et al., 1960; Jensen and McLaren, 1960;Paungfoo-Lonhienne et al., 2008). The high resistance of prions to degradation and their ability to efficiently cross biological barriers may play a role in this process. The mechanism by which plants bind, retain, uptake, and transport prions is unknown. We are currently studying the way in which prions interact with plants using purified, radioactively labeled PrPSc to determine specificity of the interaction, association constant, reversibility, saturation, movement, etc.

    Epidemiological studies have shown numerous instances of scrapie or CWD recurrence upon reintroduction of animals on pastures previously exposed to prion-infected animals. Indeed, reappearance of scrapie has been documented following fallow periods of up to 16 years (Georgsson et al., 2006), and pastures were shown to retain infectious CWD prions for at least 2 years after exposure (Miller et al., 2004). It is likely that the environmentally mediated transmission of prion diseases depends upon the interaction of prions with diverse elements, including soil, water, environmental surfaces, various invertebrate animals, and plants.

    However, since plants are such an important component of the environment and also a major source of food for many animal species, including humans, our results may have far-reaching implications for animal and human health. Currently, the perception of the riskfor animal-to-human prion transmission has beenmostly limited to consumption or exposure to contaminated meat; our results indicate that plants might also be an important vector of transmission that needs to be considered in risk assessment. 


    2020

    Monday, November 30, 2020 

    Tunisia has become the second country after Algeria to detect a case of CPD Camel Prion Disease within a year 

    REPORT OF THE MEETING OF THE OIE SCIENTIFIC COMMISSION FOR ANIMAL DISEASES Paris, 9–13 September 2019

    Scientific Commission/September 2019

    Tunisia has become the second country after Algeria to detect a case of CPD within a year

    10.2. Prion disease in dromedary camels 


    CWD AND SCRAPIE TRANSMIT TO PIGS BY ORAL ROUTES

    Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Location: Virus and Prion Research

    Title: Disease-associated prion protein detected in lymphoid tissues from pigs challenged with the agent of chronic wasting disease 

    Conclusions: This study demonstrates that PrPSc accumulates in lymphoid tissues from pigs challenged intracranially or orally with the CWD agent, and can be detected as early as 4 months after challenge. CWD-infected pigs rarely develop clinical disease and if they do, they do so after a long incubation period. This raises the possibility that CWD-infected pigs could shed prions into their environment long before they develop clinical disease. Furthermore, lymphoid tissues from CWD-infected pigs could present a potential source of CWD infectivity in the animal and human food chains.



    Research Project: Pathobiology, Genetics, and Detection of Transmissible Spongiform Encephalopathies Location: Virus and Prion Research

    Title: The agent of chronic wasting disease from pigs is infectious in transgenic mice expressing human PRNP 

    Author item MOORE, S - Orise Fellow item Kokemuller, Robyn item WEST-GREENLEE, M - Iowa State University item BALKEMA-BUSCHMANN, ANNE - Friedrich-Loeffler-institut item GROSCHUP, MARTIN - Friedrich-Loeffler-institut item Greenlee, Justin Submitted to: Prion Publication Type: Abstract Only Publication Acceptance Date: 5/10/2018 Publication Date: 5/22/2018 Citation: Moore, S.J., Kokemuller, R.D., West-Greenlee, M.H., Balkema-Buschmann, A., Groschup, M.H., Greenlee, J.J. 2018. The agent of chronic wasting disease from pigs is infectious in transgenic mice expressing human PRNP. Prion 2018, Santiago de Compostela, Spain, May 22-25, 2018. Paper No. WA15, page 44.

    Interpretive Summary:

     The successful transmission of pig-passaged CWD to Tg40 mice reported here suggests that passage of the CWD agent through pigs results in a change of the transmission characteristics which reduces the transmission barrier of Tg40 mice to the CWD agent. If this biological behavior is recapitulated in the original host species, passage of the CWD agent through pigs could potentially lead to increased pathogenicity of the CWD agent in humans.


    cwd scrapie pigs oral routes 

    ***> However, at 51 months of incubation or greater, 5 animals were positive by one or more diagnostic methods. Furthermore, positive bioassay results were obtained from all inoculated groups (oral and intracranial; market weight and end of study) suggesting that swine are potential hosts for the agent of scrapie. <*** 

    >*** Although the current U.S. feed ban is based on keeping tissues from TSE infected cattle from contaminating animal feed, swine rations in the U.S. could contain animal derived components including materials from scrapie infected sheep and goats. These results indicating the susceptibility of pigs to sheep scrapie, coupled with the limitations of the current feed ban, indicates that a revision of the feed ban may be necessary to protect swine production and potentially human health. <*** 

    ***> Results: PrPSc was not detected by EIA and IHC in any RPLNs. All tonsils and MLNs were negative by IHC, though the MLN from one pig in the oral <6 month group was positive by EIA. PrPSc was detected by QuIC in at least one of the lymphoid tissues examined in 5/6 pigs in the intracranial <6 months group, 6/7 intracranial >6 months group, 5/6 pigs in the oral <6 months group, and 4/6 oral >6 months group. Overall, the MLN was positive in 14/19 (74%) of samples examined, the RPLN in 8/18 (44%), and the tonsil in 10/25 (40%). 

    ***> Conclusions: This study demonstrates that PrPSc accumulates in lymphoid tissues from pigs challenged intracranially or orally with the CWD agent, and can be detected as early as 4 months after challenge. CWD-infected pigs rarely develop clinical disease and if they do, they do so after a long incubation period. This raises the possibility that CWD-infected pigs could shed prions into their environment long before they develop clinical disease. Furthermore, lymphoid tissues from CWD-infected pigs could present a potential source of CWD infectivity in the animal and human food chains. 




    Conclusions: This study demonstrates that PrPSc accumulates in lymphoid tissues from pigs challenged intracranially or orally with the CWD agent, and can be detected as early as 4 months after challenge. CWD-infected pigs rarely develop clinical disease and if they do, they do so after a long incubation period. This raises the possibility that CWD-infected pigs could shed prions into their environment long before they develop clinical disease. Furthermore, lymphoid tissues from CWD-infected pigs could present a potential source of CWD infectivity in the animal and human food chains.


    CONFIDENTIAL

    EXPERIMENTAL PORCINE SPONGIFORM ENCEPHALOPATHY

    LINE TO TAKE

    3. If questions on pharmaceuticals are raised at the Press conference, the suggested line to take is as follows:- 

     "There are no medicinal products licensed for use on the market which make use of UK-derived porcine tissues with which any hypothetical “high risk" ‘might be associated. The results of the recent experimental work at the CSM will be carefully examined by the CSM‘s Working Group on spongiform encephalopathy at its next meeting.

    DO Hagger RM 1533 MT Ext 3201


    While this clearly is a cause for concern we should not jump to the conclusion that this means that pigs will necessarily be infected by bone and meat meal fed by the oral route as is the case with cattle. ...


    we cannot rule out the possibility that unrecognised subclinical spongiform encephalopathy could be present in British pigs though there is no evidence for this: only with parenteral/implantable pharmaceuticals/devices is the theoretical risk to humans of sufficient concern to consider any action.


    May I, at the outset, reiterate that we should avoid dissemination of papers relating to this experimental finding to prevent premature release of the information. ...


    3. It is particularly important that this information is not passed outside the Department, until Ministers have decided how they wish it to be handled. ...


    But it would be easier for us if pharmaceuticals/devices are not directly mentioned at all. ...


    Our records show that while some use is made of porcine materials in medicinal products, the only products which would appear to be in a hypothetically ''higher risk'' area are the adrenocorticotrophic hormone for which the source material comes from outside the United Kingdom, namely America China Sweden France and Germany. The products are manufactured by Ferring and Armour. A further product, ''Zenoderm Corium implant'' manufactured by Ethicon, makes use of porcine skin - which is not considered to be a ''high risk'' tissue, but one of its uses is described in the data sheet as ''in dural replacement''. This product is sourced from the United Kingdom.....


    Sent: Fri, Aug 27, 2021 11:08 am

    Subject: Chronic Wasting Disease from pigs is infectious in transgenic mice expressing human PRNP

    FRIDAY, AUGUST 27, 2021 

    Chronic Wasting Disease from pigs is infectious in transgenic mice expressing human PRNP



    ***> CHRONIC WASTING DISEASE TSE PRP HUMANS ZOONOSIS ZOONOTIC <***

    Published: 26 September 2021

    Generation of human chronic wasting disease in transgenic mice

    Zerui Wang, Kefeng Qin, Manuel V. Camacho, Ignazio Cali, Jue Yuan, Pingping Shen, Justin Greenlee, Qingzhong Kong, James A. Mastrianni & Wen-Quan Zou

    Acta Neuropathologica Communications volume 9, Article number: 158 (2021)

    Abstract

    Chronic wasting disease (CWD) is a cervid prion disease caused by the accumulation of an infectious misfolded conformer (PrPSc) of cellular prion protein (PrPC). It has been spreading rapidly in North America and also found in Asia and Europe. Although bovine spongiform encephalopathy (i.e. mad cow disease) is the only animal prion disease known to be zoonotic, the transmissibility of CWD to humans remains uncertain. Here we report the generation of the first CWD-derived infectious human PrPSc by elk CWD PrPSc-seeded conversion of PrPC in normal human brain homogenates using in vitro protein misfolding cyclic amplification (PMCA). Western blotting with human PrP selective antibody confirmed that the PMCA-generated protease-resistant PrPSc was derived from the human PrPC substrate. Two lines of humanized transgenic mice expressing human PrP with either Val or Met at the polymorphic codon 129 developed clinical prion disease following intracerebral inoculation with the PMCA-generated CWD-derived human PrPSc. Diseased mice exhibited distinct PrPSc patterns and neuropathological changes in the brain. Our study, using PMCA and animal bioassays, provides the first evidence that CWD PrPSc can cross the species barrier to convert human PrPC into infectious PrPSc that can produce bona fide prion disease when inoculated into humanized transgenic mice.

    Snip...

    It is worth noting that the annual number of sporadic CJD (sCJD) cases in the USA has increased, with the total number of suspected and confirmed sCJD cases rising from 284 in 2003 to 511 in 2017 (https://www.cdc.gov/prions/cjd/occurrence-transmission.html). The greatly enhanced CJD surveillance and an aging population in the USA certainly contributed to the observed increase in annual sCJD case numbers in recent years, but the possibility cannot be excluded that some of the increased sCJD prevalence is linked to CWD exposure.

    In the present study, using serial protein misfolding cyclic amplification (sPMCA) assay we generate PrPSc by seeding CWD prions in normal human brain homogenates. Importantly, we reveal that two lines of humanized Tg mice expressing human PrP-129VV and 129MM develop prion diseases upon intracerebral inoculation of the abnormal PrP generated by sPMCA. We believe that our study provides the first opportunity to dissect the clinical, pathological and biochemical features of the CWD-derived human prion disease in two lines of humanized Tg mice expressing two major human PrP genotypes, respectively.


    i thought i might share some news about cwd zoonosis that i got, that i cannot share or post to the public yet, i promised for various reasons, one that it will cause a shit storm for sure, but it was something i really already knew from previous studies, but, i was told that ;

    ==================

    ''As you can imagine, 2 and 5 (especially 5) may raise alarms.  The evidence we have for 4 are not as strong or tight as I would like to have.   At this point, please do not post any of the points publicly yet, but you can refer to points 1-3 in private discussions and all 5 points when discussing with relevant public officials to highlight the long-term risks of CWD zoonosis.''

    ====================

    so, i figure your as about as official as it gets, and i think this science is extremely important for you to know and to converse about with your officials. it's about to burn a whole in my pocket. this is about as close as it will ever get for cwd zoonosis to be proven in my time, this and what Canada Czub et al found with the Macaques, plus an old study from cjd surveillance unit back that showed cjd and a 9% increase in risk from folks that eat venison, i will post all this below for your files Sir. i remember back in the BSE nvCJD days, from when the first BSE case in bovine was confirmed around 1984 maybe 83, i forget the good vets named that screwed it up first, Carol something, but from 83ish to 95 96 when nvCJD was linked to humans from BSE in cattle, so that took 10 to 15 years. hell, at that rate, especially with Texas and cwd zoonsis, hell, i'll be dead before it's official, if ever, so here ya go Sir. there was a grant study on cwd zoonosis that had been going on for some time, i followed it over the years, then the grant date for said study had expired, so, i thought i would write the good Professor about said study i.e. Professor Kong, CWRU et al. i will post the grant study abstract first, and then after that, what reply i got back, about said study that i was told not to post/publish...

    CWD ZOONOSIS GRANT FIRST;

    ===============

    Cervid to human prion transmission

    Kong, Qingzhong 

    Case Western Reserve University, Cleveland, OH, United States

     Abstract Prion disease is transmissible and invariably fatal. Chronic wasting disease (CWD) is the prion disease affecting deer, elk and moose, and it is a widespread and expanding epidemic affecting 22 US States and 2 Canadian provinces so far. CWD poses the most serious zoonotic prion transmission risks in North America because of huge venison consumption (>6 million deer/elk hunted and consumed annually in the USA alone), significant prion infectivity in muscles and other tissues/fluids from CWD-affected cervids, and usually high levels of individual exposure to CWD resulting from consumption of the affected animal among often just family and friends. However, we still do not know whether CWD prions can infect humans in the brain or peripheral tissues or whether clinical/asymptomatic CWD zoonosis has already occurred, and we have no essays to reliably detect CWD infection in humans. We hypothesize that: (1) The classic CWD prion strain can infect humans at low levels in the brain and peripheral lymphoid tissues; (2) The cervid-to-human transmission barrier is dependent on the cervid prion strain and influenced by the host (human) prion protein (PrP) primary sequence; (3) Reliable essays can be established to detect CWD infection in humans; and (4) CWD transmission to humans has already occurred. We will test these hypotheses in 4 Aims using transgenic (Tg) mouse models and complementary in vitro approaches. 

    Aim 1 will prove that the classical CWD strain may infect humans in brain or peripheral lymphoid tissues at low levels by conducting systemic bioassays in a set of humanized Tg mouse lines expressing common human PrP variants using a number of CWD isolates at varying doses and routes. Experimental human CWD samples will also be generated for Aim 3. 

    Aim 2 will test the hypothesis that the cervid-to-human prion transmission barrier is dependent on prion strain and influenced by the host (human) PrP sequence by examining and comparing the transmission efficiency and phenotypes of several atypical/unusual CWD isolates/strains as well as a few prion strains from other species that have adapted to cervid PrP sequence, utilizing the same panel of humanized Tg mouse lines as in Aim 1. 

    Aim 3 will establish reliable essays for detection and surveillance of CWD infection in humans by examining in details the clinical, pathological, biochemical and in vitro seeding properties of existing and future experimental human CWD samples generated from Aims 1-2 and compare them with those of common sporadic human Creutzfeldt-Jakob disease (sCJD) prions. 

    Aim 4 will attempt to detect clinical CWD-affected human cases by examining a significant number of brain samples from prion-affected human subjects in the USA and Canada who have consumed venison from CWD-endemic areas utilizing the criteria and essays established in Aim 3. The findings from this proposal will greatly advance our understandings on the potential and characteristics of cervid prion transmission in humans, establish reliable essays for CWD zoonosis and potentially discover the first case(s) of CWD infection in humans.

    Public Health Relevance There are significant and increasing human exposure to cervid prions because chronic wasting disease (CWD, a widespread and highly infectious prion disease among deer and elk in North America) continues spreading and consumption of venison remains popular, but our understanding on cervid-to-human prion transmission is still very limited, raising public health concerns. This proposal aims to define the zoonotic risks of cervid prions and set up and apply essays to detect CWD zoonosis using mouse models and in vitro methods. The findings will greatly expand our knowledge on the potentials and characteristics of cervid prion transmission in humans, establish reliable essays for such infections and may discover the first case(s) of CWD infection in humans.

     Funding Agency Agency National Institute of Health (NIH) Institute National Institute of Neurological Disorders and Stroke (NINDS) Type Research Project (R01) Project # 1R01NS088604-01A1 Application # 9037884 Study Section Cellular and Molecular Biology of Neurodegeneration Study Section (CMND) Program Officer Wong, May Project Start 2015-09-30 Project End 2019-07-31 Budget Start 2015-09-30 Budget End 2016-07-31 Support Year 1 Fiscal Year 2015 Total Cost $337,507 Indirect Cost $118,756

    snip... 


    Professor Kongs reply to me just this month about above grant study that has NOT been published in peer reveiw yet...

    =================================

    Here is a brief summary of our findings:

    snip...can't post, made a promise...tss

    On Sat, Apr 3, 2021 at 12:19 PM Terry Singeltary <flounder9@verizon.net> wrote:

    snip...

    end...tss

    ==============

    CWD ZOONOSIS THE FULL MONTY TO DATE

    International Conference on Emerging Diseases, Outbreaks & Case Studies & 16th Annual Meeting on Influenza March 28-29, 2018 | Orlando, USA

    Qingzhong Kong

    Case Western Reserve University School of Medicine, USA

    Zoonotic potential of chronic wasting disease prions from cervids

    Chronic wasting disease (CWD) is the prion disease in cervids (mule deer, white-tailed deer, American elk, moose, and reindeer). It has become an epidemic in North America, and it has been detected in the Europe (Norway) since 2016. The widespread CWD and popular hunting and consumption of cervid meat and other products raise serious public health concerns, but questions remain on human susceptibility to CWD prions, especially on the potential difference in zoonotic potential among the various CWD prion strains. We have been working to address this critical question for well over a decade. We used CWD samples from various cervid species to inoculate transgenic mice expressing human or elk prion protein (PrP). We found infectious prions in the spleen or brain in a small fraction of CWD-inoculated transgenic mice expressing human PrP, indicating that humans are not completely resistant to CWD prions; this finding has significant ramifications on the public health impact of CWD prions. The influence of cervid PrP polymorphisms, the prion strain dependence of CWD-to-human transmission barrier, and the characterization of experimental human CWD prions will be discussed.

    Speaker Biography Qingzhong Kong has completed his PhD from the University of Massachusetts at Amherst and Post-doctoral studies at Yale University. He is currently an Associate Professor of Pathology, Neurology and Regenerative Medicine. He has published over 50 original research papers in reputable journals (including Science Translational Medicine, JCI, PNAS and Cell Reports) and has been serving as an Editorial Board Member on seven scientific journals. He has multiple research interests, including public health risks of animal prions (CWD of cervids and atypical BSE of cattle), animal modeling of human prion diseases, mechanisms of prion replication and pathogenesis, etiology of sporadic Creutzfeldt-Jacob disease (CJD) in humans, normal cellular PrP in the biology and pathology of multiple brain and peripheral diseases, proteins responsible for the α-cleavage of cellular PrP, as well as gene therapy and DNA vaccination.






    SUNDAY, JULY 25, 2021 

    North American and Norwegian Chronic Wasting Disease prions exhibit different potential for interspecies transmission and zoonotic risk 

    ''Our data suggest that reindeer and red deer from Norway could be the most transmissible CWD prions to other mammals, whereas North American CWD prions were more prone to generate human prions in vitro.''


    MONDAY, JULY 19, 2021 

    ***> U Calgary researchers at work on a vaccine against a fatal infectious disease affecting deer and potentially people


    Prion Conference 2018 Abstracts

    BSE aka MAD COW DISEASE, was first discovered in 1984, and it took until 1995 to finally admit that BSE was causing nvCJD, the rest there is history, but that science is still evolving i.e. science now shows that indeed atypical L-type BSE, atypical Nor-98 Scrapie, and typical Scrapie are all zoonosis, zoonotic for humans, there from. 

    HOW long are we going to wait for Chronic Wasting Disease, CWD TSE Prion of Cervid, and zoonosis, zoonotic tranmission to humans there from?

    Studies have shown since 1994 that humans are susceptible to CWD TSE Prion, so, what's the hold up with making CWD a zoonotic zoonosis disease, the iatrogenic transmissions there from is not waiting for someone to make a decision.

    Prion Conference 2018 Abstracts

    P190 Human prion disease mortality rates by occurrence of chronic wasting disease in freeranging cervids, United States

    Abrams JY (1), Maddox RA (1), Schonberger LB (1), Person MK (1), Appleby BS (2), Belay ED (1)

    (1) Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA (2) Case Western Reserve University, National Prion Disease Pathology Surveillance Center (NPDPSC), Cleveland, OH, USA.

    Background

    Chronic wasting disease (CWD) is a prion disease of deer and elk that has been identified in freeranging cervids in 23 US states. While there is currently no epidemiological evidence for zoonotic transmission through the consumption of contaminated venison, studies suggest the CWD agent can cross the species barrier in experimental models designed to closely mimic humans. We compared rates of human prion disease in states with and without CWD to examine the possibility of undetermined zoonotic transmission.

    Methods

    Death records from the National Center for Health Statistics, case records from the National Prion Disease Pathology Surveillance Center, and additional state case reports were combined to create a database of human prion disease cases from 2003-2015. Identification of CWD in each state was determined through reports of positive CWD tests by state wildlife agencies. Age- and race-adjusted mortality rates for human prion disease, excluding cases with known etiology, were determined for four categories of states based on CWD occurrence: highly endemic (>16 counties with CWD identified in free-ranging cervids); moderately endemic (3-10 counties with CWD); low endemic (1-2 counties with CWD); and no CWD states. States were counted as having no CWD until the year CWD was first identified. Analyses stratified by age, sex, and time period were also conducted to focus on subgroups for which zoonotic transmission would be more likely to be detected: cases <55 years old, male sex, and the latter half of the study (2010-2015).

    Results

    Highly endemic states had a higher rate of prion disease mortality compared to non-CWD states (rate ratio [RR]: 1.12, 95% confidence interval [CI] = 1.01 - 1.23), as did low endemic states (RR: 1.15, 95% CI = 1.04 - 1.27). Moderately endemic states did not have an elevated mortality rate (RR: 1.05, 95% CI = 0.93 - 1.17). In age-stratified analyses, prion disease mortality rates among the <55 year old population were elevated for moderately endemic states (RR: 1.57, 95% CI = 1.10 – 2.24) while mortality rates were elevated among those ≥55 for highly endemic states (RR: 1.13, 95% CI = 1.02 - 1.26) and low endemic states (RR: 1.16, 95% CI = 1.04 - 1.29). In other stratified analyses, prion disease mortality rates for males were only elevated for low endemic states (RR: 1.27, 95% CI = 1.10 - 1.48), and none of the categories of CWD-endemic states had elevated mortality rates for the latter time period (2010-2015).

    Conclusions

    While higher prion disease mortality rates in certain categories of states with CWD in free-ranging cervids were noted, additional stratified analyses did not reveal markedly elevated rates for potentially sensitive subgroups that would be suggestive of zoonotic transmission. Unknown confounding factors or other biases may explain state-by-state differences in prion disease mortality.

    =====

    P172 Peripheral Neuropathy in Patients with Prion Disease

    Wang H(1), Cohen M(1), Appleby BS(1,2)

    (1) University Hospitals Cleveland Medical Center, Cleveland, Ohio (2) National Prion Disease Pathology Surveillance Center, Cleveland, Ohio.

    Prion disease is a fatal progressive neurodegenerative disease due to deposition of an abnormal protease-resistant isoform of prion protein. Typical symptoms include rapidly progressive dementia, myoclonus, visual disturbance and hallucinations. Interestingly, in patients with prion disease, the abnormal protein canould also be found in the peripheral nervous system. Case reports of prion deposition in peripheral nerves have been reported. Peripheral nerve involvement is thought to be uncommon; however, little is known about the exact prevalence and features of peripheral neuropathy in patients with prion disease.

    We reviewed autopsy-proven prion cases from the National Prion Disease Pathology Surveillance Center that were diagnosed between September 2016 to March 2017. We collected information regarding prion protein diagnosis, demographics, comorbidities, clinical symptoms, physical exam, neuropathology, molecular subtype, genetics lab, brain MRI, image and EMG reports. Our study included 104 patients. Thirteen (12.5%) patients had either subjective symptoms or objective signs of peripheral neuropathy. Among these 13 patients, 3 had other known potential etiologies of peripheral neuropathy such as vitamin B12 deficiency or prior chemotherapy. Among 10 patients that had no other clear etiology, 3 (30%) had familial CJD. The most common sCJD subtype was MV1-2 (30%), followed by MM1-2 (20%). The Majority of cases wasere male (60%). Half of them had exposure to wild game. The most common subjective symptoms were tingling and/or numbness of distal extremities. The most common objective finding was diminished vibratory sensation in the feet. Half of them had an EMG with the findings ranging from fasciculations to axonal polyneuropathy or demyelinating polyneuropathy.

    Our study provides an overview of the pattern of peripheral neuropathy in patients with prion disease. Among patients with peripheral neuropathy symptoms or signs, majority has polyneuropathy. It is important to document the baseline frequency of peripheral neuropathy in prion diseases as these symptoms may become important when conducting surveillance for potential novel zoonotic prion diseases.

    =====

    P177 PrP plaques in methionine homozygous Creutzfeldt-Jakob disease patients as a potential marker of iatrogenic transmission

    Abrams JY (1), Schonberger LB (1), Cali I (2), Cohen Y (2), Blevins JE (2), Maddox RA (1), Belay ED (1), Appleby BS (2), Cohen ML (2)

    (1) Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA (2) Case Western Reserve University, National Prion Disease Pathology Surveillance Center (NPDPSC), Cleveland, OH, USA.

    Background

    Sporadic Creutzfeldt-Jakob disease (CJD) is widely believed to originate from de novo spontaneous conversion of normal prion protein (PrP) to its pathogenic form, but concern remains that some reported sporadic CJD cases may actually be caused by disease transmission via iatrogenic processes. For cases with methionine homozygosity (CJD-MM) at codon 129 of the PRNP gene, recent research has pointed to plaque-like PrP deposition as a potential marker of iatrogenic transmission for a subset of cases. This phenotype is theorized to originate from specific iatrogenic source CJD types that comprise roughly a quarter of known CJD cases.

    Methods

    We reviewed scientific literature for studies which described PrP plaques among CJD patients with known epidemiological links to iatrogenic transmission (receipt of cadaveric human grown hormone or dura mater), as well as in cases of reported sporadic CJD. The presence and description of plaques, along with CJD classification type and other contextual factors, were used to summarize the current evidence regarding plaques as a potential marker of iatrogenic transmission. In addition, 523 cases of reported sporadic CJD cases in the US from January 2013 through September 2017 were assessed for presence of PrP plaques.

    Results

    We identified four studies describing 52 total cases of CJD-MM among either dura mater recipients or growth hormone recipients, of which 30 were identified as having PrP plaques. While sporadic cases were not generally described as having plaques, we did identify case reports which described plaques among sporadic MM2 cases as well as case reports of plaques exclusively in white matter among sporadic MM1 cases. Among the 523 reported sporadic CJD cases, 0 of 366 MM1 cases had plaques, 2 of 48 MM2 cases had kuru plaques, and 4 of 109 MM1+2 cases had either kuru plaques or both kuru and florid plaques. Medical chart review of the six reported sporadic CJD cases with plaques did not reveal clinical histories suggestive of potential iatrogenic transmission.

    Conclusions

    PrP plaques occur much more frequently for iatrogenic CJD-MM cases compared to sporadic CJDMM cases. Plaques may indicate iatrogenic transmission for CJD-MM cases without a type 2 Western blot fragment. The study results suggest the absence of significant misclassifications of iatrogenic CJD as sporadic. To our knowledge, this study is the first to describe grey matter kuru plaques in apparently sporadic CJD-MM patients with a type 2 Western blot fragment.

    =====

    P180 Clinico-pathological analysis of human prion diseases in a brain bank series

    Ximelis T (1), Aldecoa I (1,2), Molina-Porcel L (1,3), Grau-Rivera O (4), Ferrer I (5), Nos C (6), Gelpi E (1,7), Sánchez-Valle R (1,4)

    (1) Neurological Tissue Bank of the Biobanc-Hospital ClÃnic-IDIBAPS, Barcelona, Spain (2) Pathological Service of Hospital ClÃnic de Barcelona, Barcelona, Spain (3) EAIA Trastorns Cognitius, Centre Emili Mira, Parc de Salut Mar, Barcelona, Spain (4) Department of Neurology of Hospital ClÃnic de Barcelona, Barcelona, Spain (5) Institute of Neuropathology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona (6) General subdirectorate of Surveillance and Response to Emergencies in Public Health, Department of Public Health in Catalonia, Barcelona, Spain (7) Institute of Neurology, Medical University of Vienna, Vienna, Austria.

    Background and objective:

    The Neurological Tissue Bank (NTB) of the Hospital Clínic-Institut d‘Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain is the reference center in Catalonia for the neuropathological study of prion diseases in the region since 2001. The aim of this study is to analyse the characteristics of the confirmed prion diseases registered at the NTB during the last 15 years.

    Methods:

    We reviewed retrospectively all neuropathologically confirmed cases registered during the period January 2001 to December 2016.

    Results:

    176 cases (54,3% female, mean age: 67,5 years and age range: 25-86 years) of neuropathological confirmed prion diseases have been studied at the NTB. 152 cases corresponded to sporadic Creutzfeldt-Jakob disease (sCJD), 10 to genetic CJD, 10 to Fatal Familial Insomnia, 2 to GerstmannSträussler-Scheinker disease, and 2 cases to variably protease-sensitive prionopathy (VPSPr). Within sCJD subtypes the MM1 subtype was the most frequent, followed by the VV2 histotype.

    Clinical and neuropathological diagnoses agreed in 166 cases (94%). The clinical diagnosis was not accurate in 10 patients with definite prion disease: 1 had a clinical diagnosis of Fronto-temporal dementia (FTD), 1 Niemann-Pick‘s disease, 1 Lewy Body‘s Disease, 2 Alzheimer‘s disease, 1 Cortico-basal syndrome and 2 undetermined dementia. Among patients with VPSPr, 1 had a clinical diagnosis of Amyotrophic lateral sclerosis (ALS) and the other one with FTD.

    Concomitant pathologies are frequent in older age groups, mainly AD neuropathological changes were observed in these subjects.

    Discussion:

    A wide spectrum of human prion diseases have been identified in the NTB being the relative frequencies and main characteristics like other published series. There is a high rate of agreement between clinical and neuropathological diagnoses with prion diseases. These findings show the importance that public health has given to prion diseases during the past 15 years. Continuous surveillance of human prion disease allows identification of new emerging phenotypes. Brain tissue samples from these donors are available to the scientific community. For more information please visit:


    =====

    P192 Prion amplification techniques for the rapid evaluation of surface decontamination procedures

    Bruyere-Ostells L (1), Mayran C (1), Belondrade M (1), Boublik Y (2), Haïk S (3), Fournier-Wirth C (1), Nicot S (1), Bougard D (1)

    (1) Pathogenesis and control of chronic infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France. (2) Centre de Recherche en Biologie cellulaire de Montpellier, CNRS, Université de Montpellier, Montpellier, France. (3) Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.

    Aims:

    Transmissible Spongiform Encephalopathies (TSE) or prion diseases are a group of incurable and always fatal neurodegenerative disorders including Creutzfeldt-Jakob diseases (CJD) in humans. These pathologies include sporadic (sCJD), genetic and acquired (variant CJD) forms. By the past, sCJD and vCJD were transmitted by different prion contaminated biological materials to patients resulting in more than 400 iatrogenic cases (iCJD). The atypical nature and the biochemical properties of the infectious agent, formed by abnormal prion protein or PrPTSE, make it particularly resistant to conventional decontamination procedures. In addition, PrPTSE is widely distributed throughout the organism before clinical onset in vCJD and can also be detected in some peripheral tissues in sporadic CJD. Risk of iatrogenic transmission of CJD by contaminated medical device remains thus a concern for healthcare facilities. Bioassay is the gold standard method to evaluate the efficacy of prion decontamination procedures but is time-consuming and expensive. Here, we propose to compare in vitro prion amplification techniques: Protein Misfolding Cyclic Amplification (PMCA) and Real-Time Quaking Induced Conversion (RT-QuIC) for the detection of residual prions on surface after decontamination.

    Methods:

    Stainless steel wires, by mimicking the surface of surgical instruments, were proposed as a carrier model of prions for inactivation studies. To determine the sensitivity of the two amplification techniques on wires (Surf-PMCA and Surf-QuIC), steel wires were therefore contaminated with serial dilutions of brain homogenates (BH) from a 263k infected hamster and from a patient with sCJD (MM1 subtype). We then compared the different standard decontamination procedures including partially and fully efficient treatments by detecting the residual seeding activity on 263K and sCJD contaminated wires. We completed our study by the evaluation of marketed reagents endorsed for prion decontamination.

    Results:

    The two amplification techniques can detect minute quantities of PrPTSE adsorbed onto a single wire. 8/8 wires contaminated with a 10-6 dilution of 263k BH and 1/6 with the 10-8 dilution are positive with Surf-PMCA. Similar performances were obtained with Surf-QuIC on 263K: 10/16 wires contaminated with 10-6 dilution and 1/8 wires contaminated with 10-8 dilution are positive. Regarding the human sCJD-MM1 prion, Surf-QuIC allows us to detect 16/16 wires contaminated with 10-6 dilutions and 14/16 with 10-7 . Results obtained after decontamination treatments are very similar between 263K and sCJD prions. Efficiency of marketed treatments to remove prions is lower than expected.

    Conclusions:

    Surf-PMCA and Surf-QuIC are very sensitive methods for the detection of prions on wires and could be applied to prion decontamination studies for rapid evaluation of new treatments. Sodium hypochlorite is the only product to efficiently remove seeding activity of both 263K and sCJD prions.

    =====

    WA2 Oral transmission of CWD into Cynomolgus macaques: signs of atypical disease, prion conversion and infectivity in macaques and bio-assayed transgenic mice

    Schatzl HM (1, 2), Hannaoui S (1, 2), Cheng Y-C (1, 2), Gilch S (1, 2), Beekes M (3), SchulzSchaeffer W (4), Stahl-Hennig C (5) and Czub S (2, 6)

    (1) University of Calgary, Calgary Prion Research Unit, Calgary, Canada (2) University of Calgary, Faculty of Veterinary Medicine, Calgary, Canada, (3) Robert Koch Institute, Berlin, Germany, (4) University of Homburg/Saar, Homburg, Germany, (5) German Primate Center, Goettingen, Germany, (6) Canadian Food Inspection Agency (CFIA), Lethbridge, Canada.

    To date, BSE is the only example of interspecies transmission of an animal prion disease into humans. The potential zoonotic transmission of CWD is an alarming issue and was addressed by many groups using a variety of in vitro and in vivo experimental systems. Evidence from these studies indicated a substantial, if not absolute, species barrier, aligning with the absence of epidemiological evidence suggesting transmission into humans. Studies in non-human primates were not conclusive so far, with oral transmission into new-world monkeys and no transmission into old-world monkeys. Our consortium has challenged 18 Cynomolgus macaques with characterized CWD material, focusing on oral transmission with muscle tissue. Some macaques have orally received a total of 5 kg of muscle material over a period of 2 years. After 5-7 years of incubation time some animals showed clinical symptoms indicative of prion disease, and prion neuropathology and PrPSc deposition were found in spinal cord and brain of euthanized animals. PrPSc in immunoblot was weakly detected in some spinal cord materials and various tissues tested positive in RT-QuIC, including lymph node and spleen homogenates. To prove prion infectivity in the macaque tissues, we have intracerebrally inoculated 2 lines of transgenic mice, expressing either elk or human PrP. At least 3 TgElk mice, receiving tissues from 2 different macaques, showed clinical signs of a progressive prion disease and brains were positive in immunoblot and RT-QuIC. Tissues (brain, spinal cord and spleen) from these and preclinical mice are currently tested using various read-outs and by second passage in mice. Transgenic mice expressing human PrP were so far negative for clear clinical prion disease (some mice >300 days p.i.). In parallel, the same macaque materials are inoculated into bank voles. Taken together, there is strong evidence of transmissibility of CWD orally into macaques and from macaque tissues into transgenic mouse models, although with an incomplete attack rate. The clinical and pathological presentation in macaques was mostly atypical, with a strong emphasis on spinal cord pathology. Our ongoing studies will show whether the transmission of CWD into macaques and passage in transgenic mice represents a form of non-adaptive prion amplification, and whether macaque-adapted prions have the potential to infect mice expressing human PrP. The notion that CWD can be transmitted orally into both new-world and old-world non-human primates asks for a careful reevaluation of the zoonotic risk of CWD.

    See also poster P103

    ***> The notion that CWD can be transmitted orally into both new-world and old-world non-human primates asks for a careful reevaluation of the zoonotic risk of CWD.

    =====

    WA16 Monitoring Potential CWD Transmission to Humans

    Belay ED

    Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA.

    The spread of chronic wasting disease (CWD) in animals has raised concerns about increasing human exposure to the CWD agent via hunting and venison consumption, potentially facilitating CWD transmission to humans. Several studies have explored this possibility, including limited epidemiologic studies, in vitro experiments, and laboratory studies using various types of animal models. Most human exposures to the CWD agent in the United States would be expected to occur in association with deer and elk hunting in CWD-endemic areas. The Centers for Disease Control and Prevention (CDC) collaborated with state health departments in Colorado, Wisconsin, and Wyoming to identify persons at risk of CWD exposure and to monitor their vital status over time. Databases were established of persons who hunted in Colorado and Wyoming and those who reported consumption of venison from deer that later tested positive in Wisconsin. Information from the databases is periodically cross-checked with mortality data to determine the vital status and causes of death for deceased persons. Long-term follow-up of these hunters is needed to assess their risk of development of a prion disease linked to CWD exposure.

    =====

    P166 Characterization of CJD strain profiles in venison consumers and non-consumers from Alberta and Saskatchewan

    Stephanie Booth (1,2), Lise Lamoureux (1), Debra Sorensen (1), Jennifer L. Myskiw (1,2), Megan Klassen (1,2), Michael Coulthart (3), Valerie Sim (4)

    (1) Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg (2) Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg (3) Canadian CJD Surveillance System, Public Health Agency of Canada, Ottawa (4) Division of Neurology, Department of Medicine Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton.

    Chronic wasting disease (CWD) is spreading rapidly through wild cervid populations in the Canadian provinces of Alberta and Saskatchewan. While this has implications for tourism and hunting, there is also concern over possible zoonotic transmission to humans who eat venison from infected deer. Whilst there is no evidence of any human cases of CWD to date, the Canadian CJD Surveillance System (CJDSS) in Canada is staying vigilant. When variant CJD occurred following exposure to BSE, the unique biochemical fingerprint of the pathologic PrP enabled a causal link to be confirmed. However, we cannot be sure what phenotype human CWD prions would present with, or indeed, whether this would be distinct from that see in sporadic CJD. Therefore we are undertaking a systematic analysis of the molecular diversity of CJD cases of individuals who resided in Alberta and Saskatchewan at their time of death comparing venison consumers and non-consumers, using a variety of clinical, imaging, pathological and biochemical markers. Our initial objective is to develop novel biochemical methodologies that will extend the baseline glycoform and genetic polymorphism typing that is already completed by the CJDSS. Firstly, we are reviewing MRI, EEG and pathology information from over 40 cases of CJD to select clinically affected areas for further investigation. Biochemical analysis will include assessment of the levels of protease sensitive and resistant prion protein, glycoform typing using 2D gel electrophoresis, testing seeding capabilities and kinetics of aggregation by quaking-induced conversion, and determining prion oligomer size distributions with asymmetric flow field fractionation with in-line light scattering. Progress and preliminary data will be presented. Ultimately, we intend to further define the relationship between PrP structure and disease phenotype and establish a baseline for the identification of future atypical CJD cases that may arise as a result of exposure to CWD.

    =====

    Source Prion Conference 2018 Abstracts




    Volume 24, Number 8—August 2018 Research Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions

    Marcelo A. BarriaComments to Author , Adriana Libori, Gordon Mitchell, and Mark W. Head Author affiliations: National CJD Research and Surveillance Unit, University of Edinburgh, Edinburgh, Scotland, UK (M.A. Barria, A. Libori, M.W. Head); National and OIE Reference Laboratory for Scrapie and CWD, Canadian Food Inspection Agency, Ottawa, Ontario, Canada (G. Mitchell)

    Abstract Chronic wasting disease (CWD) is a contagious and fatal neurodegenerative disease and a serious animal health issue for deer and elk in North America. The identification of the first cases of CWD among free-ranging reindeer and moose in Europe brings back into focus the unresolved issue of whether CWD can be zoonotic like bovine spongiform encephalopathy. We used a cell-free seeded protein misfolding assay to determine whether CWD prions from elk, white-tailed deer, and reindeer in North America can convert the human prion protein to the disease-associated form. We found that prions can convert, but the efficiency of conversion is affected by polymorphic variation in the cervid and human prion protein genes. In view of the similarity of reindeer, elk, and white-tailed deer in North America to reindeer, red deer, and roe deer, respectively, in Europe, a more comprehensive and thorough assessment of the zoonotic potential of CWD might be warranted.

    snip...

    Discussion Characterization of the transmission properties of CWD and evaluation of their zoonotic potential are important for public health purposes. Given that CWD affects several members of the family Cervidae, it seems reasonable to consider whether the zoonotic potential of CWD prions could be affected by factors such as CWD strain, cervid species, geographic location, and Prnp–PRNP polymorphic variation. We have previously used an in vitro conversion assay (PMCA) to investigate the susceptibility of the human PrP to conversion to its disease-associated form by several animal prion diseases, including CWD (15,16,22). The sensitivity of our molecular model for the detection of zoonotic conversion depends on the combination of 1) the action of proteinase K to degrade the abundant human PrPC that constitutes the substrate while only N terminally truncating any human PrPres produced and 2) the presence of the 3F4 epitope on human but not cervid PrP. In effect, this degree of sensitivity means that any human PrPres formed during the PMCA reaction can be detected down to the limit of Western blot sensitivity. In contrast, if other antibodies that detect both cervid and human PrP are used, such as 6H4, then newly formed human PrPres must be detected as a measurable increase in PrPres over the amount remaining in the reaction product from the cervid seed. Although best known for the efficient amplification of prions in research and diagnostic contexts, the variation of the PMCA method employed in our study is optimized for the definitive detection of zoonotic reaction products of inherently inefficient conversion reactions conducted across species barriers. By using this system, we previously made and reported the novel observation that elk CWD prions could convert human PrPC from human brain and could also convert recombinant human PrPC expressed in transgenic mice and eukaryotic cell cultures (15).

    A previous publication suggested that mule deer PrPSc was unable to convert humanized transgenic substrate in PMCA assays (23) and required a further step of in vitro conditioning in deer substrate PMCA before it was able to cross the deer–human molecular barrier (24). However, prions from other species, such as elk (15) and reindeer affected by CWD, appear to be compatible with the human protein in a single round of amplification (as shown in our study). These observations suggest that different deer species affected by CWD could present differing degrees of the olecular compatibility with the normal form of human PrP.

    The contribution of the polymorphism at codon 129 of the human PrP gene has been extensively studied and is recognized as a risk factor for Creutzfeldt-Jakob disease (4). In cervids, the equivalent codon corresponds to the position 132 encoding methionine or leucine. This polymorphism in the elk gene has been shown to play an important role in CWD susceptibility (25,26). We have investigated the effect of this cervid Prnp polymorphism on the conversion of the humanized transgenic substrate according to the variation in the equivalent PRNP codon 129 polymorphism. Interestingly, only the homologs methionine homozygous seed–substrate reactions could readily convert the human PrP, whereas the heterozygous elk PrPSc was unable to do so, even though comparable amounts of PrPres were used to seed the reaction. In addition, we observed only low levels of human PrPres formation in the reactions seeded with the homozygous methionine (132 MM) and the heterozygous (132 ML) seeds incubated with the other 2 human polymorphic substrates (129 MV and 129 VV). The presence of the amino acid leucine at position 132 of the elk Prnp gene has been attributed to a lower degree of prion conversion compared with methionine on the basis of experiments in mice made transgenic for these polymorphic variants (26). Considering the differences observed for the amplification of the homozygous human methionine substrate by the 2 polymorphic elk seeds (MM and ML), reappraisal of the susceptibility of human PrPC by the full range of cervid polymorphic variants affected by CWD would be warranted.

    In light of the recent identification of the first cases of CWD in Europe in a free-ranging reindeer (R. tarandus) in Norway (2), we also decided to evaluate the in vitro conversion potential of CWD in 2 experimentally infected reindeer (18). Formation of human PrPres was readily detectable after a single round of PMCA, and in all 3 humanized polymorphic substrates (MM, MV, and VV). This finding suggests that CWD prions from reindeer could be more compatible with human PrPC generally and might therefore present a greater risk for zoonosis than, for example, CWD prions from white-tailed deer. A more comprehensive comparison of CWD in the affected species, coupled with the polymorphic variations in the human and deer PRNP–Prnp genes, in vivo and in vitro, will be required before firm conclusions can be drawn. Analysis of the Prnp sequence of the CWD reindeer in Norway was reported to be identical to the specimens used in our study (2). This finding raises the possibility of a direct comparison of zoonotic potential between CWD acquired in the wild and that produced in a controlled laboratory setting. (Table).

    The prion hypothesis proposes that direct molecular interaction between PrPSc and PrPC is necessary for conversion and prion replication. Accordingly, polymorphic variants of the PrP of host and agent might play a role in determining compatibility and potential zoonotic risk. In this study, we have examined the capacity of the human PrPC to support in vitro conversion by elk, white-tailed deer, and reindeer CWD PrPSc. Our data confirm that elk CWD prions can convert the human PrPC, at least in vitro, and show that the homologous PRNP polymorphisms at codon 129 and 132 in humans and cervids affect conversion efficiency. Other species affected by CWD, particularly caribou or reindeer, also seem able to convert the human PrP. It will be important to determine whether other polymorphic variants found in other CWD-affected Cervidae or perhaps other factors (17) exert similar effects on the ability to convert human PrP and thus affect their zoonotic potential.

    Dr. Barria is a research scientist working at the National CJD Research and Surveillance Unit, University of Edinburgh. His research has focused on understanding the molecular basis of a group of fatal neurologic disorders called prion diseases.

    Acknowledgments We thank Aru Balachandran for originally providing cervid brain tissues, Abigail Diack and Jean Manson for providing mouse brain tissue, and James Ironside for his critical reading of the manuscript at an early stage.

    This report is independent research commissioned and funded by the United Kingdom’s Department of Health Policy Research Programme and the Government of Scotland. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or the Government of Scotland.

    Author contributions: The study was conceived and designed by M.A.B. and M.W.H. The experiments were conducted by M.A.B. and A.L. Chronic wasting disease brain specimens were provided by G.M. The manuscript was written by M.A.B. and M.W.H. All authors contributed to the editing and revision of the manuscript.



    Prion 2017 Conference Abstracts
    First evidence of intracranial and peroral transmission of Chronic Wasting Disease (CWD) into Cynomolgus macaques: a work in progress Stefanie Czub1, Walter Schulz-Schaeffer2, Christiane Stahl-Hennig3, Michael Beekes4, Hermann Schaetzl5 and Dirk Motzkus6 1 
    University of Calgary Faculty of Veterinary Medicine/Canadian Food Inspection Agency; 2Universitatsklinikum des Saarlandes und Medizinische Fakultat der Universitat des Saarlandes; 3 Deutsches Primaten Zentrum/Goettingen; 4 Robert-Koch-Institut Berlin; 5 University of Calgary Faculty of Veterinary Medicine; 6 presently: Boehringer Ingelheim Veterinary Research Center; previously: Deutsches Primaten Zentrum/Goettingen 
    This is a progress report of a project which started in 2009. 
    21 cynomolgus macaques were challenged with characterized CWD material from white-tailed deer (WTD) or elk by intracerebral (ic), oral, and skin exposure routes. Additional blood transfusion experiments are supposed to assess the CWD contamination risk of human blood product. Challenge materials originated from symptomatic cervids for ic, skin scarification and partially per oral routes (WTD brain). Challenge material for feeding of muscle derived from preclinical WTD and from preclinical macaques for blood transfusion experiments. We have confirmed that the CWD challenge material contained at least two different CWD agents (brain material) as well as CWD prions in muscle-associated nerves. 
    Here we present first data on a group of animals either challenged ic with steel wires or per orally and sacrificed with incubation times ranging from 4.5 to 6.9 years at postmortem. Three animals displayed signs of mild clinical disease, including anxiety, apathy, ataxia and/or tremor. In four animals wasting was observed, two of those had confirmed diabetes. All animals have variable signs of prion neuropathology in spinal cords and brains and by supersensitive IHC, reaction was detected in spinal cord segments of all animals. Protein misfolding cyclic amplification (PMCA), real-time quaking-induced conversion (RT-QuiC) and PET-blot assays to further substantiate these findings are on the way, as well as bioassays in bank voles and transgenic mice. 
    At present, a total of 10 animals are sacrificed and read-outs are ongoing. Preclinical incubation of the remaining macaques covers a range from 6.4 to 7.10 years. Based on the species barrier and an incubation time of > 5 years for BSE in macaques and about 10 years for scrapie in macaques, we expected an onset of clinical disease beyond 6 years post inoculation. 
    PRION 2017 DECIPHERING NEURODEGENERATIVE DISORDERS ABSTRACTS REFERENCE
    8. Even though human TSE‐exposure risk through consumption of game from European cervids can be assumed to be minor, if at all existing, no final conclusion can be drawn due to the overall lack of scientific data. In particular the US data do not clearly exclude the possibility of human (sporadic or familial) TSE development due to consumption of venison. The Working Group thus recognizes a potential risk to consumers if a TSE would be present in European cervids. It might be prudent considering appropriate measures to reduce such a risk, e.g. excluding tissues such as CNS and lymphoid tissues from the human food chain, which would greatly reduce any potential risk for consumers. However, it is stressed that currently, no data regarding a risk of TSE infections from cervid products are available.


    SATURDAY, FEBRUARY 23, 2019 

    Chronic Wasting Disease CWD TSE Prion and THE FEAST 2003 CDC an updated review of the science 2019


    TUESDAY, NOVEMBER 04, 2014 

    Six-year follow-up of a point-source exposure to CWD contaminated venison in an Upstate New York community: risk behaviours and health outcomes 2005–2011

    Authors, though, acknowledged the study was limited in geography and sample size and so it couldn't draw a conclusion about the risk to humans. They recommended more study. Dr. Ermias Belay was the report's principal author but he said New York and Oneida County officials are following the proper course by not launching a study. "There's really nothing to monitor presently. No one's sick," Belay said, noting the disease's incubation period in deer and elk is measured in years. "


    Transmission Studies

    Mule deer transmissions of CWD were by intracerebral inoculation and compared with natural cases {the following was written but with a single line marked through it ''first passage (by this route)}....TSS

    resulted in a more rapidly progressive clinical disease with repeated episodes of synocopy ending in coma. One control animal became affected, it is believed through contamination of inoculum (?saline). Further CWD transmissions were carried out by Dick Marsh into ferret, mink and squirrel monkey. Transmission occurred in ALL of these species with the shortest incubation period in the ferret.

    snip.... 


    Prion Infectivity in Fat of Deer with Chronic Wasting Disease▿ 

    Brent Race#, Kimberly Meade-White#, Richard Race and Bruce Chesebro* + Author Affiliations

    In mice, prion infectivity was recently detected in fat. Since ruminant fat is consumed by humans and fed to animals, we determined infectivity titers in fat from two CWD-infected deer. Deer fat devoid of muscle contained low levels of CWD infectivity and might be a risk factor for prion infection of other species. 


    Prions in Skeletal Muscles of Deer with Chronic Wasting Disease 

    Here bioassays in transgenic mice expressing cervid prion protein revealed the presence of infectious prions in skeletal muscles of CWD-infected deer, demonstrating that humans consuming or handling meat from CWD-infected deer are at risk to prion exposure. 


    *** now, let’s see what the authors said about this casual link, personal communications years ago, and then the latest on the zoonotic potential from CWD to humans from the TOKYO PRION 2016 CONFERENCE.

    see where it is stated NO STRONG evidence. so, does this mean there IS casual evidence ???? “Our conclusion stating that we found no strong evidence of CWD transmission to humans”

    From: TSS 

    Subject: CWD aka MAD DEER/ELK TO HUMANS ???

    Date: September 30, 2002 at 7:06 am PST

    From: "Belay, Ermias"

    To: Cc: "Race, Richard (NIH)" ; ; "Belay, Ermias"

    Sent: Monday, September 30, 2002 9:22 AM

    Subject: RE: TO CDC AND NIH - PUB MED- 3 MORE DEATHS - CWD - YOUNG HUNTERS

    Dear Sir/Madam,

    In the Archives of Neurology you quoted (the abstract of which was attached to your email), we did not say CWD in humans will present like variant CJD.. That assumption would be wrong. I encourage you to read the whole article and call me if you have questions or need more clarification (phone: 404-639-3091). Also, we do not claim that "no-one has ever been infected with prion disease from eating venison." Our conclusion stating that we found no strong evidence of CWD transmission to humans in the article you quoted or in any other forum is limited to the patients we investigated.

    Ermias Belay, M.D. Centers for Disease Control and Prevention

    -----Original Message-----

    From: Sent: Sunday, September 29, 2002 10:15 AM


    Subject: TO CDC AND NIH - PUB MED- 3 MORE DEATHS - CWD - YOUNG HUNTERS

    Sunday, November 10, 2002 6:26 PM .......snip........end..............TSS

    Thursday, April 03, 2008

    A prion disease of cervids: Chronic wasting disease 2008 1: Vet Res. 2008 Apr 3;39(4):41 A prion disease of cervids: Chronic wasting disease Sigurdson CJ.

    snip...

    *** twenty-seven CJD patients who regularly consumed venison were reported to the Surveillance Center***,

    snip... full text ; 


    > However, to date, no CWD infections have been reported in people. 

    sporadic, spontaneous CJD, 85%+ of all human TSE, did not just happen. never in scientific literature has this been proven.

    if one looks up the word sporadic or spontaneous at pubmed, you will get a laundry list of disease that are classified in such a way;



    key word here is 'reported'. science has shown that CWD in humans will look like sporadic CJD. SO, how can one assume that CWD has not already transmitted to humans? they can't, and it's as simple as that. from all recorded science to date, CWD has already transmitted to humans, and it's being misdiagnosed as sporadic CJD. ...terry 

    *** LOOKING FOR CWD IN HUMANS AS nvCJD or as an ATYPICAL CJD, LOOKING IN ALL THE WRONG PLACES $$$ ***

    > However, to date, no CWD infections have been reported in people.
    key word here is ‘reported’. science has shown that CWD in humans will look like sporadic CJD. SO, how can one assume that CWD has not already transmitted to humans? they can’t, and it’s as simple as that. from all recorded science to date, CWD has already transmitted to humans, and it’s being misdiagnosed as sporadic CJD. …terry
    *** LOOKING FOR CWD IN HUMANS AS nvCJD or as an ATYPICAL CJD, LOOKING IN ALL THE WRONG PLACES $$$ ***
    *** These results would seem to suggest that CWD does indeed have zoonotic potential, at least as judged by the compatibility of CWD prions and their human PrPC target. Furthermore, extrapolation from this simple in vitro assay suggests that if zoonotic CWD occurred, it would most likely effect those of the PRNP codon 129-MM genotype and that the PrPres type would be similar to that found in the most common subtype of sCJD (MM1).***
    CWD TSE PRION AND ZOONOTIC, ZOONOSIS, POTENTIAL

    Subject: Re: DEER SPONGIFORM ENCEPHALOPATHY SURVEY & HOUND STUDY 

    Date: Fri, 18 Oct 2002 23:12:22 +0100 

    From: Steve Dealler 

    Reply-To: Bovine Spongiform Encephalopathy Organization: Netscape Online member 

    To: BSE-L@ References: <3daf5023 .4080804="" wt.net="">

    Dear Terry,

    An excellent piece of review as this literature is desparately difficult to get back from Government sites.

    What happened with the deer was that an association between deer meat eating and sporadic CJD was found in about 1993. The evidence was not great but did not disappear after several years of asking CJD cases what they had eaten. I think that the work into deer disease largely stopped because it was not helpful to the UK industry...and no specific cases were reported. Well, if you dont look adequately like they are in USA currenly then you wont find any!

    Steve Dealler =============== 


    ''The association between venison eating and risk of CJD shows similar pattern, with regular venison eating associated with a 9 FOLD INCREASE IN RISK OF CJD (p = 0.04).''

    CREUTZFELDT JAKOB DISEASE SURVEILLANCE IN THE UNITED KINGDOM THIRD ANNUAL REPORT AUGUST 1994

    Consumption of venison and veal was much less widespread among both cases and controls. For both of these meats there was evidence of a trend with increasing frequency of consumption being associated with increasing risk of CJD. (not nvCJD, but sporadic CJD...tss) These associations were largely unchanged when attention was restricted to pairs with data obtained from relatives. ...

    Table 9 presents the results of an analysis of these data.

    There is STRONG evidence of an association between ‘’regular’’ veal eating and risk of CJD (p = .0.01).

    Individuals reported to eat veal on average at least once a year appear to be at 13 TIMES THE RISK of individuals who have never eaten veal.

    There is, however, a very wide confidence interval around this estimate. There is no strong evidence that eating veal less than once per year is associated with increased risk of CJD (p = 0.51).

    The association between venison eating and risk of CJD shows similar pattern, with regular venison eating associated with a 9 FOLD INCREASE IN RISK OF CJD (p = 0.04).

    There is some evidence that risk of CJD INCREASES WITH INCREASING FREQUENCY OF LAMB EATING (p = 0.02).

    The evidence for such an association between beef eating and CJD is weaker (p = 0.14). When only controls for whom a relative was interviewed are included, this evidence becomes a little STRONGER (p = 0.08).

    snip...

    It was found that when veal was included in the model with another exposure, the association between veal and CJD remained statistically significant (p = < 0.05 for all exposures), while the other exposures ceased to be statistically significant (p = > 0.05).

    snip...

    In conclusion, an analysis of dietary histories revealed statistical associations between various meats/animal products and INCREASED RISK OF CJD. When some account was taken of possible confounding, the association between VEAL EATING AND RISK OF CJD EMERGED AS THE STRONGEST OF THESE ASSOCIATIONS STATISTICALLY. ...

    snip...

    In the study in the USA, a range of foodstuffs were associated with an increased risk of CJD, including liver consumption which was associated with an apparent SIX-FOLD INCREASE IN THE RISK OF CJD. By comparing the data from 3 studies in relation to this particular dietary factor, the risk of liver consumption became non-significant with an odds ratio of 1.2 (PERSONAL COMMUNICATION, PROFESSOR A. HOFMAN. ERASMUS UNIVERSITY, ROTTERDAM). (???...TSS)

    snip...see full report ;




    Stephen Dealler is a consultant medical microbiologist  deal@airtime.co.uk 

    BSE Inquiry Steve Dealler

    Management In Confidence

    BSE: Private Submission of Bovine Brain Dealler

    snip...see full text;

    MONDAY, FEBRUARY 25, 2019

    ***> MAD DOGS AND ENGLISHMEN BSE, SCRAPIE, CWD, CJD, TSE PRION A REVIEW 2019


    ***> ''The association between venison eating and risk of CJD shows similar pattern, with regular venison eating associated with a 9 FOLD INCREASE IN RISK OF CJD (p = 0.04).''

    ***> In conclusion, sensory symptoms and loss of reflexes in Gerstmann-Sträussler-Scheinker syndrome can be explained by neuropathological changes in the spinal cord. We conclude that the sensory symptoms and loss of lower limb reflexes in Gerstmann-Sträussler-Scheinker syndrome is due to pathology in the caudal spinal cord. <***

    ***> The clinical and pathological presentation in macaques was mostly atypical, with a strong emphasis on spinal cord pathology.<*** 

    ***> The notion that CWD can be transmitted orally into both new-world and old-world non-human primates asks for a careful reevaluation of the zoonotic risk of CWD. <***

    ***> All animals have variable signs of prion neuropathology in spinal cords and brains and by supersensitive IHC, reaction was detected in spinal cord segments of all animals.<*** 

    ***> In particular the US data do not clearly exclude the possibility of human (sporadic or familial) TSE development due to consumption of venison. The Working Group thus recognizes a potential risk to consumers if a TSE would be present in European cervids.'' Scientific opinion on chronic wasting disease (II) <***


    North American and Norwegian Chronic Wasting Disease prions exhibit different potential for interspecies transmission and zoonotic risk

    Sandra Pritzkow1,*, Damian Gorski1,*, Frank Ramirez1 , Glenn C. Telling2 , Sylvie L. Benestad3 and Claudio Soto1,#

    1 Mitchell Center for Alzheimer's disease and related Brain disorders, Department of Neurology, University of Texas McGovern Medical School at Houston, Texas, USA 2 Prion Research Center, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA 3 Norwegian Veterinary Institute, OIE Reference Laboratory for CWD, Oslo, Norway.

    Summary: We investigated the in vitro spillover and zoonotic potential of CWD from various cervid species. Our results suggest that Norway CWD prions have a higher potential to infect other animals, but NorthAmerican CWD appear more prone to generate human prions.

    The current evidence for CWD transmission to humans is controversial; indeed, while transgenic mice expressing human PrP did not develop disease when challenged with CWD prions in various laboratories [6-8, 41], experimental inoculation of CWD into squirrel monkeys produced disease [9, 10]. Studies in macaques, which are phylogenetically closer to humans than squirrel monkeys [45] have shown mixed results. A study from Czub and colleagues found that CWD prions can induce disease and pathologic abnormalities typical of prion disease in macaques exposed to CWD prions, even by oral inoculation of muscle tissue from cervids affected by CWD [46]. However, a different study found no evidence for prion disease in macaques inoculated with CWD [47]. To assess the cervid/human species barrier, we previously used PMCA to determine prion replication in vitro. We found that, after stabilization by successive passages in deer PrPC, PrPSc from CWD infected deer can convert human PrPC into a novel form of PrPSc [13]. Our current study to evaluate in vitro zoonotic potential of various CWD prions showed that although the cervid/human barrier is large, we were able to observe generation of human PrPSc with some specific CWD strains in a second round of PMCA (Fig. 5). The three North American CWD isolates were capable to sustain generation of human PrPSc, with white-tailed deer showing the highest efficiency. Conversely, none of the three Norway CWD isolates generated any detectable PrPSc signal up to the second round of PMCA. This data suggest that North American CWD prions might be of a greater risk to humans than the infected animals in Northern Europe. We speculate that these differences might be due to Norwegian CWD being less stable prion strains as compared to North American CWD, which have had longer time to replicate in cervids and become stabilized through many rounds of natural infection. Our findings may provide important information to understand the diversity of natural CWD prion strains in different animals across distinct geographical areas and their consequences for the spillover into other animal species, including humans.


    MONDAY, JULY 19, 2021 

    U Calgary researchers at work on a vaccine against a fatal infectious disease affecting deer and potentially people


    TUESDAY, JULY 13, 2021

    Chronic Wasting Disease and the Canadian Agriculture and Agri-food Sectors Current Knowledge Risks and Policy Options

    ''The science is progressing on the possibility of transmission of CWD to humans through oral transmission, but the complete assessment of this possibility remains to be done.''


    MONDAY, DECEMBER 16, 2019 

    Chronic Wasting Disease CWD TSE Prion aka mad cow type disease in cervid Zoonosis Update

    ***> ''In particular the US data do not clearly exclude the possibility of human (sporadic or familial) TSE development due to consumption of venison. The Working Group thus recognizes a potential risk to consumers if a TSE would be present in European cervids.'' Scientific opinion on chronic wasting disease (II) <***

    What if?


    TUESDAY, MAY 11, 2021 
     
    A Unique Presentation of Creutzfeldt-Jakob Disease in a Patient Consuming Deer Antler Velvet

    Conclusion

    We believe that our patient’s case of CJD is highly suspicious for cervid etiology given the circumstances of the case as well as the strong evidence of plausibility reported in published literature. This is the first known case of CJD in a patient who had consumed deer antler velvet. Despite the confirmed diagnosis of CJD, a causal relationship between the patient’s disease and his consumption of deer antler velvet cannot be definitively concluded.

    Supplemental data including molecular tissue sample analysis and autopsy findings could yield further supporting evidence. Given this patient’s clinical resemblance to CBD and the known histological similarities of CBD with CJD, clinicians should consider both diseases in the differential diagnosis of patients with a similarly esoteric presentation. Regardless of the origin of this patient’s disease, it is clear that the potential for prion transmission from cervids to humans should be further investigated by the academic community with considerable urgency. 


    ''We believe that our patient’s case of CJD is highly suspicious for cervid etiology given the circumstances of the case as well as the strong evidence of plausibility reported in published literature. This is the first known case of CJD in a patient who had consumed deer antler velvet. Despite the confirmed diagnosis of CJD, a causal relationship between the patient’s disease and his consumption of deer antler velvet cannot be definitively concluded.''
     

    ABOUT that deer antler spray and CWD TSE PRION...
     
    I have been screaming this since my neighbors mom died from cjd, and she had been taking a supplement that contained bovine brain, bovine eyeball, and other SRMs specified risk materials, the most high risk for mad cow disease.
    just saying...
     
    I made a submission to the BSE Inquiry long ago during the BSE Inquiry days, and they seemed pretty interested.
     
    Sender: "Patricia Cantos"
     
    To: "Terry S Singeltary Sr. (E-mail)"
     
    Subject: Your submission to the Inquiry
     
    Date: Fri, 3 Jul 1998 10:10:05 +0100
     
    3 July 1998
     
    Mr Terry S Singeltary Sr.
     
    E-Mail: Flounder at wt.net
     
    Ref: E2979
     
    Dear Mr Singeltary,
     
    Thank you for your E-mail message of the 30th of June 1998 providing the Inquiry with your further comments.
     
    Thank you for offering to provide the Inquiry with any test results on the nutritional supplements your mother was taking before she died.
     
    As requested I am sending you our general Information Pack and a copy of the Chairman's letter. Please contact me if your system cannot read the attachments.
     
    Regarding your question, the Inquiry is looking into many aspects of the scientific evidence on BSE and nvCJD. I would refer you to the transcripts of evidence we have already heard which are found on our internet site at ;
     
     
    Could you please provide the Inquiry with a copy of the press article you refer to in your e-mail? If not an approximate date for the article so that we can locate it?
     
    In the meantime, thank you for you comments. Please do not hesitate to contact me on...
     
    snip...end...tss
     
    everyone I tell this too gets it screwed up...MY MOTHER WAS NOT TAKING THOSE SUPPLEMENTS IPLEX (that I ever knew of). this was my neighbors mother that died exactly one year _previously_ and to the day of sporadic CJD that was diagnosed as Alzheimer’s at first. my mother died exactly a year later from the Heidenhain Variant of Creutzfeldt Jakob Disease hvCJD, and exceedingly rare strains of the ever growing sporadic CJD’s. _both_ cases confirmed. ...kind regards, terry
     
    TSEs i.e. mad cow disease's BSE/BASE and NUTRITIONAL SUPPLEMENTS
     
    IPLEX, mad by standard process;
     
    vacuum dried bovine BRAIN, bone meal, bovine EYE, veal Bone, bovine liver powder, bovine adrenal, vacuum dried bovine kidney, and vacuum dried porcine stomach.
     
    also;
     
    what about potential mad cow candy bars ?
     
    see their potential mad cow candy bar list too...
     
    THESE are just a few of MANY of just this ONE COMPANY...TSS
     
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
     
    FOOD AND DRUG ADMINISTRATION CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
     
    TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE
     
    Friday, January 19, 2001 snip...
     
    17 But I think that we could exhibit some quite
     
    18 reasonable concern about blood donors who are taking dietary
     
    19 supplements that contain a certain amount of unspecified-
     
    20 origin brain, brain-related, brain and pituitary material.
     
    21 If they have done this for more than a sniff or something
     
    22 like that, then, perhaps, they should be deferred as blood
     
    23 donors.
     
    24 That is probably worse than spending six months in
     
    25 the U.K.
     
    1/19/01
     
    3681t2.rtf(845) page 501
     
     
     
     
    see full text ;
     

    Saturday, May 1, 2021 

    Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease

    ***Moreover, sporadic disease has never been observed in breeding colonies or primate research laboratories, most notably among hundreds of animals over several decades of study at the National Institutes of Health25, and in nearly twenty older animals continuously housed in our own facility.***

    Even if the prevailing view is that sporadic CJD is due to the spontaneous formation of CJD prions, it remains possible that its apparent sporadic nature may, at least in part, result from our limited capacity to identify an environmental origin.

    https://www.nature.com/articles/srep11573 

    O.05: Transmission of prions to primates after extended silent incubation periods: Implications for BSE and scrapie risk assessment in human populations 
    Emmanuel Comoy, Jacqueline Mikol, Valerie Durand, Sophie Luccantoni, Evelyne Correia, Nathalie Lescoutra, Capucine Dehen, and Jean-Philippe Deslys Atomic Energy Commission; Fontenay-aux-Roses, France 

    Prion diseases (PD) are the unique neurodegenerative proteinopathies reputed to be transmissible under field conditions since decades. The transmission of Bovine Spongiform Encephalopathy (BSE) to humans evidenced that an animal PD might be zoonotic under appropriate conditions. Contrarily, in the absence of obvious (epidemiological or experimental) elements supporting a transmission or genetic predispositions, PD, like the other proteinopathies, are reputed to occur spontaneously (atpical animal prion strains, sporadic CJD summing 80% of human prion cases). 

    Non-human primate models provided the first evidences supporting the transmissibiity of human prion strains and the zoonotic potential of BSE. Among them, cynomolgus macaques brought major information for BSE risk assessment for human health (Chen, 2014), according to their phylogenetic proximity to humans and extended lifetime. We used this model to assess the zoonotic potential of other animal PD from bovine, ovine and cervid origins even after very long silent incubation periods. 

    *** We recently observed the direct transmission of a natural classical scrapie isolate to macaque after a 10-year silent incubation period, 

    ***with features similar to some reported for human cases of sporadic CJD, albeit requiring fourfold long incubation than BSE. Scrapie, as recently evoked in humanized mice (Cassard, 2014), 

    ***is the third potentially zoonotic PD (with BSE and L-type BSE), 

    ***thus questioning the origin of human sporadic cases. 

    We will present an updated panorama of our different transmission studies and discuss the implications of such extended incubation periods on risk assessment of animal PD for human health. 

    =============== 

    ***thus questioning the origin of human sporadic cases*** 

    =============== 

    ***our findings suggest that possible transmission risk of H-type BSE to sheep and human. Bioassay will be required to determine whether the PMCA products are infectious to these animals. 

    ============== 

    https://prion2015.files.wordpress.com/2015/05/prion2015abstracts.pdf 

    ***Transmission data also revealed that several scrapie prions propagate in HuPrP-Tg mice with efficiency comparable to that of cattle BSE. While the efficiency of transmission at primary passage was low, subsequent passages resulted in a highly virulent prion disease in both Met129 and Val129 mice. 

    ***Transmission of the different scrapie isolates in these mice leads to the emergence of prion strain phenotypes that showed similar characteristics to those displayed by MM1 or VV2 sCJD prion. 

    ***These results demonstrate that scrapie prions have a zoonotic potential and raise new questions about the possible link between animal and human prions. 

    http://www.tandfonline.com/doi/abs/10.1080/19336896.2016.1163048?journalCode=kprn20 

    PRION 2016 TOKYO

    Saturday, April 23, 2016

    SCRAPIE WS-01: Prion diseases in animals and zoonotic potential 2016

    Prion. 10:S15-S21. 2016 ISSN: 1933-6896 printl 1933-690X online

    Taylor & Francis

    Prion 2016 Animal Prion Disease Workshop Abstracts

    WS-01: Prion diseases in animals and zoonotic potential

    Transmission of the different scrapie isolates in these mice leads to the emergence of prion strain phenotypes that showed similar characteristics to those displayed by MM1 or VV2 sCJD prion. 

    These results demonstrate that scrapie prions have a zoonotic potential and raise new questions about the possible link between animal and human prions. 

    http://www.tandfonline.com/doi/abs/10.1080/19336896.2016.1163048?journalCode=kprn20

    Title: Transmission of scrapie prions to primate after an extended silent incubation period) 

    *** In complement to the recent demonstration that humanized mice are susceptible to scrapie, we report here the first observation of direct transmission of a natural classical scrapie isolate to a macaque after a 10-year incubation period. Neuropathologic examination revealed all of the features of a prion disease: spongiform change, neuronal loss, and accumulation of PrPres throughout the CNS. 

    *** This observation strengthens the questioning of the harmlessness of scrapie to humans, at a time when protective measures for human and animal health are being dismantled and reduced as c-BSE is considered controlled and being eradicated. 

    *** Our results underscore the importance of precautionary and protective measures and the necessity for long-term experimental transmission studies to assess the zoonotic potential of other animal prion strains. 

    http://www.ars.usda.gov/research/publications/publications.htm?SEQ_NO_115=313160

    ***> Scrapie vs Chronic Wasting Disease CWD TSE Prion ???

    172. Establishment of PrPCWD extraction and detection methods in the farm soil

    Kyung Je Park, Hoo Chang Park, In Soon Roh, Hyo Jin Kim, Hae-Eun Kang and Hyun Joo Sohn

    Foreign Animal Disease Division, Animal and Plant Quarantine Agency, Gimcheon, Gyeongsangbuk-do, Korea

    Conclusions: Our studies showed that PrPCWD persist in 0.001% CWD contaminated soil for at least 4 year and natural CWD-affected farm soil. When cervid reintroduced into CWD outbreak farm, the strict decontamination procedures of the infectious agent should be performed in the environment of CWD-affected cervid habitat.


    Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Location: Virus and Prion Research

    Title: Scrapie transmits to white-tailed deer by the oral route and has a molecular profile similar to chronic wasting disease

    Author 

     item Greenlee, Justin item Moore, S - Orise Fellow item Smith, Jodi - Iowa State University item Kunkle, Robert item West Greenlee, M - Iowa State University Submitted to: American College of Veterinary Pathologists Meeting Publication Type: Abstract Only Publication Acceptance Date: 8/12/2015 Publication Date: N/A Citation: N/A

    Interpretive Summary:

    Technical Abstract: The purpose of this work was to determine susceptibility of white-tailed deer (WTD) to the agent of sheep scrapie and to compare the resultant PrPSc to that of the original inoculum and chronic wasting disease (CWD). We inoculated WTD by a natural route of exposure (concurrent oral and intranasal (IN); n=5) with a US scrapie isolate. All scrapie-inoculated deer had evidence of PrPSc accumulation. PrPSc was detected in lymphoid tissues at preclinical time points, and deer necropsied after 28 months post-inoculation had clinical signs, spongiform encephalopathy, and widespread distribution of PrPSc in neural and lymphoid tissues. Western blotting (WB) revealed PrPSc with 2 distinct molecular profiles. WB on cerebral cortex had a profile similar to the original scrapie inoculum, whereas WB of brainstem, cerebellum, or lymph nodes revealed PrPSc with a higher profile resembling CWD. Homogenates with the 2 distinct profiles from WTD with clinical scrapie were further passaged to mice expressing cervid prion protein and intranasally to sheep and WTD. In cervidized mice, the two inocula have distinct incubation times. Sheep inoculated intranasally with WTD derived scrapie developed disease, but only after inoculation with the inoculum that had a scrapie-like profile. The WTD study is ongoing, but deer in both inoculation groups are positive for PrPSc by rectal mucosal biopsy. In summary, this work demonstrates that WTD are susceptible to the agent of scrapie, two distinct molecular profiles of PrPSc are present in the tissues of affected deer, and inoculum of either profile readily passes to deer.


    ***> “In summary, this work demonstrates that WTD are susceptible to the agent of scrapie, two distinct molecular profiles of PrPSc are present in the tissues of affected deer, and inoculum of either profile readily passes to deer.”

    223. Scrapie in white-tailed deer: a strain of the CWD agent that efficiently transmits to sheep?

    Justin J. Greenleea, Robyn D. Kokemullera, S. Jo Moorea and Heather West Greenleeb

    aVirus and Prion Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, Ames, IA, USA; bDepartment of Biomedical Sciences, Iowa State University College of Veterinary Medicine, Ames, IA, USA

    CONTACT Justin J. Greenlee Justin.Greenlee@ars.usda.gov

    ABSTRACT

    Scrapie is a transmissible spongiform encephalopathy of sheep and goats that is associated with widespread accumulation of abnormal prion protein (PrPSc) in the central nervous and lymphoid tissues. Chronic wasting disease (CWD) is the natural prion disease of cervid species, and the tissue distribution of PrPSc in affected cervids is similar to scrapie in sheep. There are several lines of evidence that suggest that multiple strains of CWD exist, which may affect the agent’s potential to transmit to hosts of the same or different species. We inoculated white-tailed deer with the scrapie agent from ARQ/ARQ sheep, which resulted in 100% attack rates by either the intracranial or oronasal route of inoculation. When examining tissues from the brainstems or lymphoid tissues by traditional diagnostic methods such as immunohistochemistry or western blots, it is difficult to differentiate tissues from deer infected with scrapie from those infected with CWD. However, there are several important differences between tissues from scrapie-infected white-tailed deer (WTD scrapie) and those infected with CWD (WTD CWD). First, there are different patterns of PrPSc deposition in the brains of infected deer: brain tissues from deer with WTD scrapie had predominantly particulate and stellate immunoreactivity whereas those from deer with WTD-CWD had large aggregates and plaque-like deposits. Secondly, the incubation periods of WTD scrapie isolates are longer than CWD isolates in mice expressing cervid prion protein. Most notably, the transmission potential of these two isolates back to sheep is distinctly different. Attempts to transmit various CWD isolates to sheep by the oral or oronasal routes have been unsuccessful despite observation periods of up to 7 years. However, WTD scrapie efficiently transmitted back to sheep by the oronasal route. Upon transmission back to sheep, the WTD scrapie isolate exhibited different phenotypic properties when compared to the sheep receiving the original sheep scrapie inoculum including different genotype susceptibilities, distinct PrPSc deposition patterns, and much more rapid incubation periods in transgenic mice expressing the ovine prion protein. The scrapie agent readily transmits between sheep and deer after oronasal exposure. This could confound the identification of CWD strains in deer and the eradication of scrapie from sheep.


    ***> “The scrapie agent readily transmits between sheep and deer after oronasal exposure. This could confound the identification of CWD strains in deer and the eradication of scrapie from sheep.”

    Title: Scrapie transmits to white-tailed deer by the oral route and has a molecular profile similar to chronic wasting disease


    J Vet Diagn Invest . 2021 Jul;33(4):711-720. doi: 10.1177/10406387211017615. Epub 2021 May 28. D Cassmann 1, Rylie D Frese 1, Justin J Greenlee 1

    Affiliations expand PMID: 34047228 PMCID: PMC8229824 (available on 2022-05-28)DOI: 10.1177/10406387211017615 Full text linksCite Abstract

    The origin of chronic wasting disease (CWD) in cervids is unclear. One hypothesis suggests that CWD originated from scrapie in sheep. We compared the disease phenotype of sheep-adapted CWD to classical scrapie in sheep. We inoculated sheep intracranially with brain homogenate from first-passage mule deer CWD in sheep (sCWDmd). The attack rate in second-passage sheep was 100% (12 of 12). Sheep had prominent lymphoid accumulations of PrPSc reminiscent of classical scrapie. The pattern and distribution of PrPSc in the brains of sheep with CWDmd was similar to scrapie strain 13-7 but different from scrapie strain x124. The western blot glycoprofiles of sCWDmd were indistinguishable from scrapie strain 13-7; however, independent of sheep genotype, glycoprofiles of sCWDmd were different than x124. When sheep genotypes were evaluated individually, there was considerable overlap in the glycoprofiles that precluded significant discrimination between sheep CWD and scrapie strains. Our data suggest that the phenotype of CWD in sheep is indistinguishable from some strains of scrapie in sheep. Given our results, current detection techniques would be unlikely to distinguish CWD in sheep from scrapie in sheep if cross-species transmission occurred naturally. It is unknown if sheep are naturally vulnerable to CWD; however, the susceptibility of sheep after intracranial inoculation and lymphoid accumulation indicates that the species barrier is not absolute.

    Keywords: PrPSc proteins; chronic wasting disease; deer; prions; scrapie; sheep.


    ***> ”Our data suggest that the phenotype of CWD in sheep is indistinguishable from some strains of scrapie in sheep. Given our results, current detection techniques would be unlikely to distinguish CWD in sheep from scrapie in sheep if cross-species transmission occurred naturally.”


    Title: Second passage of chronic wasting disease of mule deer in sheep compared to classical scrapie after intracranial inoculation

    Taken together, these data suggest that the phenotype of CWD in sheep is indistinguishable from some strains of scrapie in sheep. 


    ''We inoculated WTD by a natural route of exposure (concurrent oral and intranasal (IN); n=5) with a US scrapie isolate. All scrapie-inoculated deer had evidence of PrPSc accumulation.''

    Title: Passage of scrapie to deer results in a new phenotype upon return passage to sheep


    Title: Transmission of the agent of sheep scrapie to deer results in PrPSc with two distinct molecular profiles 

    ***> In summary, this work demonstrates that WTD are susceptible to the agent of scrapie, two distinct molecular profiles of PrPSc are present in the tissues of affected deer, and inoculum of either profile type readily passes to deer. 




    COLORADO THE ORIGIN OF CHRONIC WASTING DISEASE CWD TSE PRION?

    *** Spraker suggested an interesting explanation for the occurrence of CWD. The deer pens at the Foot Hills Campus were built some 30-40 years ago by a Dr. Bob Davis. At or about that time, allegedly, some scrapie work was conducted at this site. When deer were introduced to the pens they occupied ground that had previously been occupied by sheep.


    3.2.1.2 Non‐cervid domestic species

    The remarkably high rate of natural CWD transmission in the ongoing NA epidemics raises the question of the risk to livestock grazing on CWD‐contaminated shared rangeland and subsequently developing a novel CWD‐related prion disease. This issue has been investigated by transmitting CWD via experimental challenge to cattle, sheep and pigs and to tg mouse lines expressing the relevant species PrP.

    For cattle challenged with CWD, PrPSc was detected in approximately 40% of intracerebrally inoculated animals (Hamir et al., 2005, 2006a, 2007). Tg mice expressing bovine PrP have also been challenged with CWD and while published studies have negative outcomes (Tamguney et al., 2009b), unpublished data provided for the purposes of this Opinion indicate that some transmission of individual isolates to bovinised mice is possible (Table 1).

    In small ruminant recipients, a low rate of transmission was reported between 35 and 72 months post‐infection (mpi) in ARQ/ARQ and ARQ/VRQ sheep intracerebrally challenged with mule deer CWD (Hamir et al., 2006b), while two out of two ARQ/ARQ sheep intracerebrally inoculated with elk CWD developed clinical disease after 28 mpi (Madsen‐Bouterse et al., 2016). However, tg mice expressing ARQ sheep PrP were resistant (Tamguney et al., 2006) and tg mice expressing the VRQ PrP allele were poorly susceptible to clinical disease (Beringue et al., 2012; Madsen‐Bouterse et al., 2016). In contrast, tg mice expressing VRQ sheep PrP challenged with CWD have resulted in highly efficient, life‐long asymptomatic replication of these prions in the spleen tissue (Beringue et al., 2012).

    A recent study investigated the potential for swine to serve as hosts of the CWD agent(s) by intracerebral or oral challenge of crossbred piglets (Moore et al., 2016b, 2017). Pigs sacrificed at 6 mpi, approximately the age at which pigs reach market weight, were clinically healthy and negative by diagnostic tests, although low‐level CWD agent replication could be detected in the CNS by bioassay in tg cervinised mice. Among pigs that were incubated for up to 73 mpi, some gave diagnostic evidence of CWD replication in the brain between 42 and 72 mpi. Importantly, this was observed also in one orally challenged pig at 64 mpi and the presence of low‐level CWD replication was confirmed by mouse bioassay. The authors of this study argued that pigs can support low‐level amplification of CWD prions, although the species barrier to CWD infection is relatively high and that the detection of infectivity in orally inoculated pigs with a mouse bioassay raises the possibility that naturally exposed pigs could act as a reservoir of CWD infectivity.


    FDA BSE PART 589 SUBSTANCES PROHIBITED Ruminant Feed Inspections Firms Inventory Report Official Action Indicated OAI and VAI November 2021 

    November 04, 2021


    FIRST OFF, spontaneous/sporadic CJD and a brief history of spontaneous sporadic cjd science put forth to date, history there from.

    let's compare apple to oranges first I.E. spontaneous sporadic TSE Prion Primates Research Laboratories

    ***Moreover, sporadic disease has never been observed in breeding colonies or primate research laboratories, most notably among hundreds of animals over several decades of study at the National Institutes of Health25, and in nearly twenty older animals continuously housed in our own facility.***

    Even if the prevailing view is that sporadic CJD is due to the spontaneous formation of CJD prions, it remains possible that its apparent sporadic nature may, at least in part, result from our limited capacity to identify an environmental origin.

    https://www.nature.com/articles/srep11573 

    NEXT, just what does spontaneous/sporadic, mean?

    sporadic, spontaneous CJD, 85%+ of all human TSE, just not just happen. never in scientific literature has this been proven.

    if one looks up the word sporadic or spontaneous at pubmed, you will get a laundry list of disease that are classified in such a way;

    sporadic = 68,704 results for definition of various diseases https://www.ncbi.nlm.nih.gov/pubmed/?term=sporadic

    spontaneous = 444,312 results for definition of various diseases https://www.ncbi.nlm.nih.gov/pubmed/?term=spontaneous 

    SO PLEASE, the least we could do is define what spontaneous and sporadic, in terms of Transmissible Spongiform Encephalopathy TSE Prion disease are, define exactly what that means, for those that still think 85%+ of all human TSE Prion disease i.e. and this is a very broad term including vpspr, sffi, sgss, and SPORADIC CJD, for those that still believe all sCJD is just a happening of a spontaneous even of a protein flipping out on it's own, with no cause, just happens, in 85%+ of all human TSE Prion, without a shread of documented evidence to prove this. the UKBSEnvCJD only theory is, was, and will be, not scientific, and we must move away from that. With the science at hand, animal transmission studies, molecular studies, there is enough evidence to date, (as much today, as there was back in 1995 linking nvCJD to c-BSE), to declare that there is evidence that if not all, some of the sporadic CJD strains are indeed a zoonosis disease, or, are a iatrogenic event from either a zoonotic source by friendly fire, pass it forward, from a subclinical host from said sporadic CJD cases, from either CWD in cervid, BSE in cattle, or Scrapie in sheep and goats, both typical and atypical, and all of the above have now been linked by science to the infamous spontaneous/sporadic CJDs. we have wasted too much effort on the UKBSEnvCJD only theory imo. for the announcement for science to link nvcjd to humans from UK c-BSE in 1984 or 1985, it took an additional 10 years to finally make the call that nvcjd was infecting humans in 1995. i think BSE started actually before Carol Richardson and the case there (see source references below) , but we can't wait for another 10 years for a call to be made for zoonosis of CWD, BSE, and Scrapie, for some of the cases, if not all, of the sporadic CJDs as zoonosis disease. to continue this thinking, will only allow the TSE Prion disease to continue to be spread via iatrogenic events. we cannot wash our hands of these events, with a spontaneous or sporadic ideology. WE MUST MOVE FORWARD WITH THE ZOONOISIS science of sporadic CJD as zoonosis, and work ourselves down from there, trying to prove it's not, instead of spreading to hell and back around the globe for 5 decades or so, saying it is not, without proof. i think science has been screaming for over a decade that indeed, sporadic CJD, is zoonosis, and govern from there. THIS CHARADE MUST END!

    CJD is not reportable in all states, but no evidence of increase in the number of cases has been observed in the U.S. However, the NPDPSC examines about 64% of the approximately 300 cases expected to occur in the U.S. per year...

    expected to occur in the U.S. per year???

    oxymoron

    you must have _all_ key components of a math formula to correctly solve a math problem, or in this case, figuring statistics. yet we don't have all the key components. 

    not all states report cjd tse prion, and some that do, only report in 55 and older, yet some do make in reportable of all ages. plus, you figure in misdiagnosis, that's another key element/component, it happens. 

    for example;

    CJD is not a reportable disease in West Virginia. Because the disease is 100% fatal the occurrence of CJD is tracked through death certificates.


    I would kindly like to add to my initial concerns, something I brought up years ago, and I believe that still hold true today, more so even than when I first stated these concerns in 2003 ; 

     routine passive mortality CJD surveillance USA ? 

    THIS has been proven not to be very useful in the U.K.; 

    THE EPIDEMIOLOGY OF CJD RG WILL 1984 (182 PAGES)

    snip...

    One reason for this was the _inaccuracy_ in coding of cases correctly certified as CJD Coding is carried out by staff who are not medically qualified and it is not surprising that coding errors occur in the processing of large numbers of certificates. In 1982, 12,000 certificates per week were processed at the office of population censuses and surveys by 15 coders and 6 checkers (Alderson et al., 1983). The occurrence of both inter- and intra-observer coding errors has been described (Curb et al., 1983) and the _inaccuracies_ of BOTH certification and coding discovered in this study _support_ the introduction of a more accurate system of death certificates and a more detailed and specific coding system...

    snip...



    Draft Proposal For The Monitoring of Creutzfeldt-Jakob Disease 1989 Dr. R. Will

    snip...

    IDENTIFICATION OF CASES

    Cases of CJD may be identified from death certificates, but this alone is unlikely to provide adequate monitoring. ERRORS are made in certification and diagnosis; in the Oxford study death certificates were obtained on a series of known confirmed cases and CJD was mentioned in only 66% of certificates. In another series of 175 certified cases, 42 patients were judged not to have suffered from CJD after examination of case notes (7)...

    full text;



    Confucius is confused again? how in 1996 and earlier can the 28 sporadic CJD victims and the one-in-a-million there from, how can it still be one in a million in 2008, with the sporadic CJD count rising to 205, still be one-in-a-million? and the years in-between, steady rise just about every year, and it still be only one-in-a-million, year after year after years? I suppose just more of that fuzzy math, which you can see here;


    Please see my complete comment to this synopsis here ;

    Saturday, January 2, 2010

    Human Prion Diseases in the United States January 1, 2010

    see full text;

    re-Human Prion Diseases in the United States 

    Posted by flounder on 01 Jan 2010 at 18:11 GMT 

    I kindly disagree with your synopsis for the following reasons ; 

    snip...

    Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States 2003 revisited 2009

    August 10, 2009

    Greetings,

    I would like to submit a review of past CJD surveillance in the USA, and the urgent need to make all human TSE in the USA a reportable disease, in every state, of every age group, and to make this mandatory immediately without further delay. The ramifications of not doing so will only allow this agent to spread further in the medical, dental, surgical arena's. North America seems to have the most species with documented Transmissible Spongiform Encephalopathy's, most all of which have been rendered and fed back to food producing animals and to humans for years. If you look at the statistics, sporadic CJD seems to be rising in the USA, and has been, with atypical cases of the sCJD. I find deeply disturbing in the year of 2009, that Human Transmissible Spongiform Encephalopathy of any strain and or phenotype, of all age groups, and I stress all age groups, because human TSE's do not know age, and they do not know borders. someone 56 years old, that has a human TSE, that has surgery, can pass this TSE agent on i.e. friendly fire, and or passing it forward, and there have been documented nvCJD in a 74 year old. Remembering also that only sporadic CJD has been documented to transmit via iatrogenic routes, until recently with the 4 cases of blood related transmission, of which the origin is thought to be nvCJD donors. However most Iatrogenic CJD cases are nothing more than sporadic CJD, until the source is proven, then it becomes Iatrogenic. An oxymoron of sorts, because all sporadic CJD is, are multiple forms, or strains, or phenotypes of Creutzfeldt Jakob Disease, that the route and source and species have not been confirmed and or documented. When will the myth of the UKBSEnvCJD only theory be put to bed for good. This theory in my opinion, and the following there from, as the GOLD STANDARD, has done nothing more than help spread this agent around the globe. Politics and money have caused the terrible consequences to date, and the fact that TSEs are a slow incubating death, but a death that is 100% certain for those that are exposed and live long enough to go clinical. once clinical, there is no recourse, to date. But, while sub-clinical, how many can one exposed human infect? Can humans exposed to CWD and scrapie strains pass it forward as some form of sporadic CJD in the surgical and medical arenas? why must we wait decades and decades to prove this point, only to expose millions needlessly, only for the sake of the industries involved? would it not have been prudent from the beginning to just include all TSE's, and rule them out from there with transmission studies and change policies there from, as opposed to doing just the opposite? The science of TSE's have been nothing more than a political circus since the beginning, and for anyone to still believe in this one strain, one group of bovines, in one geographical location, with only one age group of human TSE i.e. nvCJD myth, for anyone to believe this today only enhances to spreading of these human and animal TSE's. This is exactly why we have been in this quagmire.

    The ones that believe that there is a spontaneous CJD in 85%+ of all cases of human TSE, and the ones that do not believe that cattle can have this same phenomenon, are two of the same, the industry, and so goes the political science aspect of this tobacco and or asbestos scenario i.e. follow the money. I could go into all angles of this man made nightmare, the real facts and science, for instance, the continuing rendering technology and slow cooking with low temps that brewed this stew up, and the fact that THE USA HAD THIS TECHNOLOGY FIRST AND SHIPPED IT TO THE U.K. SOME 5 YEARS BEFORE THE U.S. STARTED USING THE SAME TECHNOLOGY, to save on fuel cost. This is what supposedly amplified the TSE agent via sheep scrapie, and spread via feed in the U.K. bovine, and other countries exporting the tainted product. BUT most everyone ignores this fact, and the fact that the U.S. has been recycling more TSE, from more species with TSEs, than any other country documented, but yet, it's all spontaneous, and the rise in sporadic CJD in the U.S. is a happenstance of bad luck ??? I respectfully disagree. To top that all off, the infamous BSE-FIREWALL that the USDA always brags about was nothing more than ink on paper, and I can prove this. YOU can ignore it, but this is FACT (see source, as late as 2007, in one recall alone, some 10,000,000 MILLION POUNDS OF BANNED MAD COW FEED WENT OUT INTO COMMERCE TO BE FED OUT, and most was never recovered. This was banned blood laced, meat and bone meal. 2006 was a banner year for banned mad cow protein going into commerce in the U.S. (see source of FDA feed ban warning letter below). I stress that the August 4, 1997 USA mad cow feed ban and this infamous BSE firewall, was nothing more than ink on paper, it was never enforceable.

    I propose that the current diagnostic criteria for human TSEs only enhances and helps the spreading of human TSE from the continued belief of the UKBSEnvCJD only theory in 2009. With all the science to date refuting it, to continue to validate this old myth, will only spread this TSE agent through a multitude of potential routes and sources i.e. consumption, medical i.e., surgical, blood, dental, endoscopy, optical, nutritional supplements, cosmetics etc. I propose as with Aguzzi, Asante, Collinge, Caughey, Deslys, Dormont, Gibbs, Gajdusek, Ironside, Manuelidis, Marsh, et al and many more, that the world of TSE Transmissible Spongiform Encephalopathy is far from an exact science, but there is enough proven science to date that this myth should be put to rest once and for all, and that we move forward with a new classification for human and animal TSE that would properly identify the infected species, the source species, and then the route. This would further have to be broken down to strain of species and then the route of transmission would further have to be broken down. Accumulation and Transmission are key to the threshold from sub- clinical to clinical disease, and key to all this, is to stop the amplification and transmission of this agent, the spreading of, no matter what strain. In my opinion, to continue with this myth that the U.K. strain of BSE one strain TSE in cows, and the nv/v CJD one strain TSE humans, and the one geographical location source i.e. U.K., and that all the rest of human TSE are just one single strain i.e. sporadic CJD, a happenstance of bad luck that just happens due to a twisted protein that just twisted the wrong way, IN 85%+ OF ALL HUMAN TSEs, when to date there are 6 different phenotypes of sCJD, and growing per Gambetti et al, and that no other animal TSE transmits to humans ??? With all due respect to all Scientist that believe this, I beg to differ. To continue with this masquerade will only continue to spread, expose, and kill, who knows how many more in the years and decades to come. ONE was enough for me, My Mom, hvCJD i.e. Heidenhain Variant CJD, DOD 12/14/97 confirmed, which is nothing more than another mans name added to CJD, like CJD itself, Jakob and Creutzfeldt, or Gerstmann-Straussler-Scheinker syndrome, just another CJD or human TSE, named after another human. WE are only kidding ourselves with the current diagnostic criteria for human and animal TSE, especially differentiating between the nvCJD vs the sporadic CJD strains and then the GSS strains and also the FFI fatal familial insomnia strains or the ones that mimics one or the other of those TSE? Tissue infectivity and strain typing of the many variants of the human and animal TSEs are paramount in all variants of all TSE. There must be a proper classification that will differentiate between all these human TSE in order to do this. With the CDI and other more sensitive testing coming about, I only hope that my proposal will some day be taken seriously. ...

    please see history, and the ever evolving TSE science to date ;

    Saturday, June 13, 2009

    Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States 2003 revisited 2009


    Diagnosis and Reporting of Creutzfeldt-Jakob Disease Singeltary, Sr et al. 

    JAMA.2001; 285: 733-734. Vol. 285 No. 6, February 14, 2001 JAMA 

    Diagnosis and Reporting of Creutzfeldt-Jakob Disease 

    To the Editor: In their Research Letter, Dr Gibbons and colleagues1 reported that the annual US death rate due to Creutzfeldt-Jakob disease (CJD) has been stable since 1985. These estimates, however, are based only on reported cases, and do not include misdiagnosed or preclinical cases. It seems to me that misdiagnosis alone would drastically change these figures. An unknown number of persons with a diagnosis of Alzheimer disease in fact may have CJD, although only a small number of these patients receive the postmortem examination necessary to make this diagnosis. Furthermore, only a few states have made CJD reportable. Human and animal transmissible spongiform encephalopathies should be reportable nationwide and internationally.. 

    Terry S. Singeltary, Sr Bacliff, Tex 1. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA. 2000;284:2322-2323. 


    January 28, 2003; 60 (2) VIEWS & REVIEWS

    RE-Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States Terry S. Singeltary, retired (medically) 

    Published March 26, 2003

    26 March 2003

    Terry S. Singeltary, retired (medically) CJD WATCH

    I lost my mother to hvCJD (Heidenhain Variant CJD). I would like to comment on the CDC's attempts to monitor the occurrence of emerging forms of CJD. Asante, Collinge et al [1] have reported that BSE transmission to the 129-methionine genotype can lead to an alternate phenotype that is indistinguishable from type 2 PrPSc, the commonest sporadic CJD. However, CJD and all human TSEs are not reportable nationally. CJD and all human TSEs must be made reportable in every state and internationally. I hope that the CDC does not continue to expect us to still believe that the 85%+ of all CJD cases which are sporadic are all spontaneous, without route/source. We have many TSEs in the USA in both animal and man. CWD in deer/elk is spreading rapidly and CWD does transmit to mink, ferret, cattle, and squirrel monkey by intracerebral inoculation. With the known incubation periods in other TSEs, oral transmission studies of CWD may take much longer. Every victim/family of CJD/TSEs should be asked about route and source of this agent. To prolong this will only spread the agent and needlessly expose others. In light of the findings of Asante and Collinge et al, there should be drastic measures to safeguard the medical and surgical arena from sporadic CJDs and all human TSEs. I only ponder how many sporadic CJDs in the USA are type 2 PrPSc?


    Reply to Singletary 26 March 2003

    Ryan A. Maddox, MPH

    Mr. Singletary raises several issues related to current Creutzfeldt- Jakob disease (CJD) surveillance activities. Although CJD is not a notifiable disease in most states, its unique characteristics, particularly its invariably fatal outcome within usually a year of onset, make routine mortality surveillance a useful surrogate for ongoing CJD surveillance.[1] In addition, because CJD is least accurately diagnosed early in the course of illness, notifiable-disease surveillance could be less accurate than, if not duplicative of, current mortality surveillance.[1] However, in states where making CJD officially notifiable would meaningfully facilitate the collection of data to monitor for variant CJD (vCJD) or other emerging prion diseases, CDC encourages the designation of CJD as a notifiable disease.[1] Moreover, CDC encourages physicians to report any diagnosed or suspected CJD cases that may be of special public health importance (e.g., vCJD, iatrogenic CJD, unusual CJD clusters).

    As noted in our article, strong evidence is lacking for a causal link between chronic wasting disease (CWD) of deer and elk and human disease,[2] but only limited data seeking such evidence exist. Overall, the previously published case-control studies that have evaluated environmental sources of infection for sporadic CJD have not consistently identified strong evidence for a common risk factor.[3] However, the power of a case-control study to detect a rare cause of CJD is limited, particularly given the relatively small number of subjects generally involved and its long incubation period, which may last for decades. Because only a very small proportion of the US population has been exposed to CWD, a targeted surveillance and investigation of unusual cases or case clusters of prion diseases among persons at increased risk of exposure to CWD is a more efficient approach to detecting the possible transmission of CWD to humans. In collaboration with appropriate local and state health departments and the National Prion Disease Pathology Surveillance Center, CDC is facilitating or conducting such surveillance and case- investigations, including related laboratory studies to characterize CJD and CWD prions.

    Mr. Singletary also expresses concern over a recent publication by Asante and colleagues indicating the possibility that some sporadic CJD cases may be attributable to bovine spongiform encephalopathy (BSE).[4] The authors reported that transgenic mice expressing human prion protein homozygous for methionine at codon 129, when inoculated with BSE prions, developed a molecular phenotype consistent with a subtype of sporadic CJD. Although the authors implied that BSE might cause a sporadic CJD-like illness among persons homozygous for methionine, the results of their research with mice do not necessarily directly apply to the transmission of BSE to humans. If BSE causes a sporadic CJD-like illness in humans, an increase in sporadic CJD cases would be expected to first occur in the United Kingdom, where the vast majority of vCJD cases have been reported. In the United Kingdom during 1997 through 2002, however, the overall average annual mortality rate for sporadic CJD was not elevated; it was about 1 case per million population per year. In addition, during this most recent 6-year period following the first published description of vCJD in 1996, there was no increasing trend in the reported annual number of UK sporadic CJD deaths.[3, 5] Furthermore, surveillance in the UK has shown no increase in the proportion of sporadic CJD cases that are homozygous for methionine (Will RG, National CJD Surveillance Unit, United Kingdom, 2003; personal communication).

    References

    1. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Diagnosis and reporting of Creutzfeldt-Jakob disease. JAMA 2001;285:733-734.

    2. Belay ED, Maddox RA, Gambetti P, Schonberger LB. Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology 2003;60:176-181.

    3. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol 1999;53:283-314.

    4. Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002;21:6358-6366.

    5. The UK Creutzfeldt-Jakob Disease Surveillance Unit. CJD statistics. Available at: http://www.cjd.ed.ac.uk/figures.htm. Accessed February 18, 2003.



    SPORADIC CJD LAYING ODDS


    In brief

    BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7226.8/b (Published 01 January 2000)

    Cite this as: BMJ 2000;320:8

    Rapid Response:

    02 January 2000

    Terry S Singeltary

    retired

    U.S. Scientist should be concerned with a CJD epidemic in the U.S., as well... In reading your short article about 'Scientist warn of CJD epidemic' news in brief Jan. 1, 2000. I find the findings in the PNAS old news, made famous again. Why is the U.S. still sitting on their butts, ignoring the facts? We have the beginning of a CJD epidemic in the U.S., and the U.S. Gov. is doing everything in it's power to conceal it.

    The exact same recipe for B.S.E. existed in the U.S. for years and years. In reading over the Qualitative Analysis of BSE Risk Factors-1, this is a 25 page report by the USDA:APHIS:VS. It could have been done in one page. The first page, fourth paragraph says it all;

    "Similarities exist in the two countries usage of continuous rendering technology and the lack of usage of solvents, however, large differences still remain with other risk factors which greatly reduce the potential risk at the national level."

    Then, the next 24 pages tries to down-play the high risks of B.S.E. in the U.S., with nothing more than the cattle to sheep ratio count, and the geographical locations of herds and flocks. That's all the evidence they can come up with, in the next 24 pages.

    Something else I find odd, page 16;

    "In the United Kingdom there is much concern for a specific continuous rendering technology which uses lower temperatures and accounts for 25 percent of total output. This technology was _originally_ designed and imported from the United States. However, the specific application in the production process is _believed_ to be different in the two countries."

    A few more factors to consider, page 15;

    "Figure 26 compares animal protein production for the two countries. The calculations are based on slaughter numbers, fallen stock estimates, and product yield coefficients. This approach is used due to variation of up to 80 percent from different reported sources. At 3.6 million tons, the United States produces 8 times more animal rendered product than the United Kingdom."

    "The risk of introducing the BSE agent through sheep meat and bone meal is more acute in both relative and absolute terms in the United Kingdom (Figures 27 and 28). Note that sheep meat and bone meal accounts for 14 percent, or 61 thousand tons, in the United Kingdom versus 0.6 percent or 22 thousand tons in the United States. For sheep greater than 1 year, this is less than one-tenth of one percent of the United States supply."

    "The potential risk of amplification of the BSE agent through cattle meat and bone meal is much greater in the United States where it accounts for 59 percent of total product or almost 5 times more than the total amount of rendered product in the United Kingdom."

    Considering, it would only take _one_ scrapie infected sheep to contaminate the feed. Considering Scrapie has run rampant in the U.S. for years, as of Aug. 1999, 950 scrapie infected flocks. Also, Considering only one quarter spoonful of scrapie infected material is lethal to a cow.

    Considering all this, the sheep to cow ration is meaningless. As I said, it's 24 pages of B.S.e.

    To be continued...

    Terry S. Singeltary Sr.

    Bacliff, Texas USA

    Competing interests: No competing interests


    Rapid response to:

    US scientists develop a possible test for BSE

    15 November 1999

    Terry S Singeltary

    NA

    BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7220.1312b (Published 13 November 1999)

    Cite this as: BMJ 1999;319:1312

    Article Related content Article metrics 

    Rapid responses 

    Response Rapid Response: Re: vCJD in the USA * BSE in U.S. In reading the recent article in the BMJ about the potential BSE tests being developed in the U.S. and Bart Van Everbroeck reply. It does not surprize me, that the U.S. has been concealing vCJD. There have been people dying from CJD, with all the symptoms and pathological findings that resemble U.K. vCJD for some time. It just seems that when there is one found, they seem to change the clerical classification of the disease, to fit their agenda. I have several autopsies, stating kuru type amyloid plaques, one of the victims was 41 years of age. Also, my Mom died a most hideous death, Heidenhain Variant Creutzfeldt Jakob disease. Her symptoms resemble that of all the U.K. vCJD victims. She would jerk so bad at times, it would take 3 of us to hold her down, while she screamed "God, what's wrong with me, why can't I stop this." 1st of symptoms to death, 10 weeks, she went blind in the first few weeks. But, then they told me that this was just another strain of sporadic CJD. They can call it what ever they want, but I know what I saw, and what she went through. Sporadic, simply means, they do not know. My neighbors Mom also died from CJD. She had been taking a nutritional supplement which contained the following; vacuum dried bovine BRAIN, bone meal, bovine EYE, veal bone, bovine liver powder, bovine adrenal, vacuum dried bovine kidney, and vacuum dried porcine stomach. As I said, this woman taking these nutritional supplements, died from CJD. The particular batch of pills that was located, in which she was taking, was tested. From what I have heard, they came up negative, for the prion protein. But, in the same breath, they said their testing, may not have been strong enough to pick up the infectivity. Plus, she had been taking these type pills for years, so, could it have come from another batch?

    CWD is just a small piece of a very big puzzle. I have seen while deer hunting, deer, squirrels and birds, eating from cattle feed troughs where they feed cattle, the high protein cattle by products, at least up until Aug. 4, 1997.

    So why would it be so hard to believe that this is how they might become infected with a TSE. Or, even by potentially infected land. It's been well documented that it could be possible, from scrapie. Cats becoming infected with a TSE. Have you ever read the ingredients on the labels of cat and dog food? But, they do not put these tissues from these animals in pharmaceuticals, cosmetics, nutritional supplements, hGH, hPG, blood products, heart valves, and the many more products that come from bovine, ovine, or porcine tissues and organs. So, as I said, this CWD would be a small piece of a very big puzzle. But, it is here, and it most likely has killed. You see, greed is what caused this catastrophe, rendering and feeding practices. But, once Pandora's box was opened, the potential routes of infection became endless.

    No BSE in the U.S.A.? I would not be so sure of that considering that since 1990;

    Since 1990 the U.S. has raised 1,250,880,700 cattle;

    Since 1990 the U.S. has ONLY checked 8,881 cattle brains for BSE, as of Oct. 4, 1999;

    There are apprx. 100,000 DOWNER cattle annually in the U.S., that up until Aug. 4, 1997 went to the renders for feed;

    Scrapie running rampant for years in the U.S., 950 infected FLOCKS, as of Aug. 1999;

    Our feeding and rendering practices have mirrored that of the U.K. for years, some say it was worse. Everything from the downer cattle, to those scrapie infected sheep, to any roadkill, including the city police horse and the circus elephant went to the renders for feed and other products for consumption. Then they only implemented a partial feed ban on Aug. 4, 1997, but pigs, chickens, dogs, and cats, and humans were exempt from that ban. So they can still feed pigs and chickens those potentially TSE tainted by-products, and then they can still feed those by-products back to the cows. I believe it was Dr. Joe Gibbs, that said, the prion protein, can survive the digestional track. So you have stopped nothing. It was proven in Oprah Winfrey's trial, that Cactus Cattle feeders, sent neurologically ill cattle, some with encephalopathy stamped on the dead slips, were picked up and sent to the renders, along with sheep carcasses. Speaking of autopsies, I have a stack of them, from CJD victims. You would be surprised of the number of them, who ate cow brains, elk brains, deer brains, or hog brains.

    I believe all these TSE's are going to be related, and originally caused by the same greedy Industries, and they will be many. Not just the Renders, but you now see, that they are re-using medical devices that were meant for disposal. Some medical institutions do not follow proper auto-claving procedures (even Olympus has put out a medical warning on their endoscopes about CJD, and the fact you cannot properly clean these instruments from TSE's), and this is just one product. Another route of infection.

    Regardless what the Federal Government in the U.S. says. It's here, I have seen it, and the longer they keep sweeping it under the rug and denying the fact that we have a serious problem, one that could surpass aids (not now, but in the years to come, due to the incubation period), they will be responsible for the continued spreading of this deadly disease.

    It's their move, it's CHECK, but once CHECKMATE has been called, how many thousands or millions, will be at risk or infected or even dead. You can't play around with these TSE's. I cannot stress that enough. They are only looking at body bags, and the fact the count is so low. But, then you have to look at the fact it is not a reportable disease in most states, mis-diagnosis, no autopsies performed. The fact that their one-in-a- million theory is a crude survey done about 5 years ago, that's a joke, under the above circumstances. A bad joke indeed...

    The truth will come, but how many more have to die such a hideous death. It's the Government's call, and they need to make a serious move, soon. This problem, potential epidemic, is not going away, by itself.

    Terry S. Singeltary Sr.

    Bacliff, Texas 77518 USA


    Competing interests: No competing interests


    doi:10.1016/S1473-3099(03)00715-1 Copyright © 2003 Published by Elsevier Ltd. Newsdesk

    Tracking spongiform encephalopathies in North America

    Xavier Bosch

    Available online 29 July 2003. 

    Volume 3, Issue 8, August 2003, Page 463 

    “My name is Terry S Singeltary Sr, and I live in Bacliff, Texas. I lost my mom to hvCJD (Heidenhain variant CJD) and have been searching for answers ever since. What I have found is that we have not been told the truth. CWD in deer and elk is a small portion of a much bigger problem..” 



    Scientific Advisors and Consultants Staff 2001 Advisory Committee TSE PRION Singeltary Submission 

    Freas Monday, January 08,2001 3:03 PM 

    FDA Singeltary submission 2001 

    Greetings again Dr. Freas and Committee Members, 

    I wish to submit the following information to the Scientific Advisors and Consultants Staff 2001 Advisory Committee (short version). I understand the reason of having to shorten my submission, but only hope that you add it to a copy of the long version, for members to take and read at their pleasure, (if cost is problem, bill me, address below). So when they realize some time in the near future of the 'real' risks i speak of from human/animal TSEs and blood/surgical products. I cannot explain the 'real' risk of this in 5 or 10 minutes at some meeting, or on 2 or 3 pages, but will attempt here: 

    snip...see full text ; 


    Subject: Prion Scientific Advisors and Consultants Staff Meeting Singeltary Submission Freas Monday, January 08,2001 3:03 PM

    PLEASE be aware, my submission here has now been removed from the www, or changed to a different url that no one knows now, and does not come up in search engines anymore, after 17 years...wonder why that could be, i guess the truth just hurt to much$$$ 

    Freas, William

    From: Terry S. Singeltary Sr. [flounder@wt.net]

    Sent: Monday, January 08,2001 3:03 PM


    Subject: CJD/BSE (aka madcow) Human/Animal TSE’s--U.S.--Submission To Scientific Advisors and Consultants Staff January 2001 Meeting (short version)

    CJD/BSE (aka madcow) Human/Animal TSE’s--U.S.--Submission To Scientific Advisors and Consultants Staff January 2001 Meeting (short version)

    Greetings again Dr. Freas and Committee Members,

    I wish to submit the following information to the Scientific Advisors and Consultants Staff 2001 Advisory Committee (short version).

    I understand the reason of having to shorten my submission, but only hope that you add it to a copy of the long version, for members to take and read at their pleasure, (if cost is problem, bill me, address below). So when they realize some time in the near future of the 'real' risks i speak of from human/animal TSEs and blood/surgical products. I cannot explain the 'real' risk of this in 5 or 10 minutes at some meeting, or on 2 or 3 pages, but will attempt here:

    remember AIDS/HIV, 'no problem to heterosexuals in the U.S.? no need to go into that, you know of this blunder:

    DO NOT make these same stupid mistakes again with human/animal TSE's aka MADCOW DISEASE. I lost my Mom to hvCJD, and my neighbor lost his Mother to sCJD as well (both cases confirmed). I have seen many deaths, from many diseases. I have never seen anything as CJD, I still see my Mom laying helpless, jerking tremendously, and screaming "God, what's wrong with me, why can't I stop this". I still see this, and will never forget. Approximately 10 weeks from 1st of symptoms to death. This is what drives me. I have learned more in 3 years about not only human/animal TSE's but the cattle/rendering/feeding industry/government than i ever wished to.

    I think you are all aware of CJD vs vCJD, but i don't think you all know the facts of human/animal TSE's as a whole, they are all very very similar, and are all tied to the same thing, GREED and MAN.

    I am beginning to think that the endless attempt to track down and ban, potential victims from known BSE Countries from giving blood will be futile. You would have to ban everyone on the Globe eventually? AS well, I think we MUST ACT SWIFTLY to find blood test for TSE's, whether it be blood test, urine test, .eyelid test, anything at whatever cost, we need a test FAST.

    DO NOT let the incubation time period of these TSEs fool you.

    To think of Scrapie as the prime agent to compare CJD, but yet overlook the Louping-ill vaccine event in 1930's of which 1000's of sheep where infected by scrapie from a vaccine made of scrapie infected sheep brains, would be foolish. I acquired this full text version of the event which was recorded in the Annual Congress of 1946 National Vet. Med. Ass. of Great Britain and Ireland. from the BVA and the URL is posted in my (long version).

    U.S.A. should make all human/animal TSE's notifiable at all ages, with requirements for a thorough surveillance and post-mortem examinations free of charge, if you are serious about eradicating this horrible disease in man and animal.

    There is histopathology reports describing o florid plaques" in CJD victims in the USA and some of these victims are getting younger. I have copies of such autopsies, there has to be more. PLUS, sub-clinical human TSE's will most definitely be a problem.

    THEN think of vaccineCJD in children and the bovine tissues used in the manufacturing process, think of the FACT that this agent surviving 6OO*C. PNAS -- Brown et al. 97 (7): 3418 scrapie agent live at 600*C

    Then think of the CONFIDENTIAL documents of what was known of human/animal TSE and vaccines in the mid to late 80s, it was all about depletion of stock, to hell with the kids, BUT yet they knew. To think of the recall and worry of TSE's from the polio vaccine, (one taken orally i think?), but yet neglect to act on the other potential TSE vaccines (inoculations, the most effective mode to transmit TSEs) of which thousands of doses were kept and used, to deplete stockpile, again would be foolish.

    --Oral polio; up to 1988, foetal calf serum was used from UK and New Zealand (pooled); since 1988 foetal calf serum only from New Zealand. Large stocks are held.

    --Rubella; bulk was made before 1979 from foetal calf serum from UK and New Zealand. None has been made as there are some 15 years stock.

    --Diphtheria; UK bovine beef muscle and ox heart is used but since the end of 1988 this has been sourced from Eire. There are 1,250 litres of stock.

    --Tetanus; this involves bovine material from the UK mainly Scottish. There are 21,000 litres of stock.

    --Pertussis; uses bovine material from the UK. There are 63,000 litres of stock. --They consider that to switch to a non-UK source will take a minimum of 6-18 months and to switch to a non-bovine source will take a minimum of five years.

    3. XXXXXXXXXXX have measles, mumps, MMR, rubella vaccines. These are sourced from the USA and the company believes that US material only is used.

    89/2.14/2.1

    ============

    BSE3/1 0251

    4. XXXXXXXXXXX have a measles vaccine using bovine serum from the UK. there are 440,000 units of stock. They have also got MMR using bovine serum from the UK.

    5. XXXXXXXXXXX have influenza, rubella, measles,' MMR vaccines likely to be used in children. Of those they think that only MMR contains bovine material which is probably a French origin.

    6. XXXXXXXXXXX have diphtheria/tetanus and potasses on clinical trial. hese use veal material, some of which has come from the UK and has been ade by XXXXXXXXXXX (see above).

    I have documents of imports from known BSE Countries, of ferments, whole blood, antiallergenic preparations,


    human blood plasma, normal human blood sera, human immune blood sera, fetal bovine serum, and other blood fractions not elsewhere specified or included, imported glands, catgut, vaccines for both human/animal, as late as 1998. Let us not forget about PITUITARY EXTRACT. This was used to help COWS super ovulate. This tissue was considered to be of greatest risk of containing BSE and consequently transmitting the disease.

    ANNEX 6

    MEETING HELD ON 8 JUNE 1988 TO DISCUSS THE IMPLICATIONS OF BSE TO BIOLOGICAL PRODUCTS CONTAINING BOVINE - EXTRACTED MATERIAL

    How much of this was used in the U.S.?

    Please do not keep making the same mistakes; 'Absence of evidence is not evidence of absence'.

    What are the U.S. rules for importing and manufacturing vaccines, medicines and medical devices?

    Does the U.S.A. allow sourcing of raw material of ruminants from the U.S.A.?

    U.S. cattle, what kind of guarantee can you give for serum or tissue donor herds? The U.S. rendering system would easily amplify T.S.E.'s:

    Have we increased the stability of the system (improved heat treatments) since the EU SSC report on the U.S.A. was published in july 2000?

    What is done to avoid cross-contaminations in the U.S.A.?

    How can the U.S. control absence of cross-contaminations of animal TSE's when pig and horse MBM and even deer and elk are allowed in ruminant feed, as well as bovine blood? I sadly think of the rendering and feeding policy before the Aug. 4, 1997 'partial' feed ban, where anything went, from the city police horse, to the circus elephant, i will not mention all the scrapie infected sheep. I am surprised that we have not included man 'aka soyent green'. It is a disgusting industry and nothing more than greed fuels it.

    When will the U.S.. start real surveillance of the U.S. bovine population (not passive, this will not work)?

    When will U.S. start removing SRMs?

    Have they stopped the use of pneumatic stunners in the U.S.?

    If so, will we stop it in all U.S. abattoirs or only in those abattoirs exporting to Europe?

    If not, WHY NOT?

    same questions for removal of SRM in the U.S.A., or just for export?

    If not, WHY NOT?

    How do we now sterilize surgical/dental instruments in the U.S.A.?

    Where have we been sourcing surgical catgut?

    (i have copies of imports to U.S., and it would floor you) hen will re-usable surgical instruments be banned?

    'Unregulated "foods" such as 'nutritional supplements' containing various extracts from ruminants, whether imported or derived from


    US cattle/sheep/cervids ("antler velvet" extracts!) should be forbidden or at least very seriously regulated. (neighbors Mom, whom also died from CJD, had been taking bovine based supplement, which contained brain, eye, and many other bovine/ovine tissues for years, 'IPLEX').

    What is the use of banning blood or tissue donors from Germany, France, etc... when the U.S.A. continues exposing cattle, sheep and people to SRM, refuses to have a serious feed ban, refuses to do systematic BSE-surveillance?

    The FDA should feel responsible for the safety of what people eat, prohibit the most dangerous foods, not only prohibit a few more donors - the FDA should be responsible for the safe sourcing of medical devices, not only rely on banning donors "from Europe", The 'real' risks are here in the U.S. as well, and nave been for some time.

    We must not forget the studies that have proven infectivity in blood from TSE's.

    The Lancet, November 9, 1985

    Sir, --Professor Manuelidis and his colleagues (Oct 19, p896) report transmission to animals of Creutzfeldt-Jakob disease (CJD) from the buffy coat from two patients. We also transmitted the disease from, whole blood samples of a patient (and of mice) infected with CJD.l Brain, Cornea, and urine from this patient were also infectious, and the clinicopathological findings2 are summarised as follows.

    snip...

    Samples,were taken aseptically at necropsy. 10% crude homogenates of brain and cornea in saline, whole blood (after crushing a clot), and untreated CSF and urine were innoculated intracerebrally into CFl strain mice (20 ul per animal). Some mice showed emaciation, bradykinesia, rigidity of the body and tail, and sometimes tremor after long incubation periods. Tissues obtained after the animal died (or was killed) were studied histologically (table). Animals infected by various inocula showed common pathological changes, consisting of severe spongiform changes, glial proliferation, and a moderate loss of nerve cells. A few mice inoculated with brain tissue or urine had the same amyloid plaques found in patients and animals with CJD.3

    snip...

    Department of Neuropathology,. Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka812, Japan JUN TATEISHI

    (full text-long version)

    and

    CWD and transmission to man will be no different than other TSE's.

    "Clearly, it is premature to draw firm conclusions about CWD passing naturally into humans, cattle and sheep, but the present results suggest that CWD transmissions to humans would be as limited by PrP incompatibility as transmissions of BSE or sheep scrapie to humans. Although there is no evidence that sheep scrapie has affected humans, it is likely that BSE has

    4

    caused variant CJD in 74 people (definite and probable variant CJD cases to date according to the UK CJD Surveillance Unit). Given the presumably large number of people exposed to BSE infectivity, the susceptibility of humans may still be very low compared with cattle, which would be consistent with the relatively inefficient conversion of human PrP-sen by PrPBSE. Nonetheless, since humans have apparently been infected by BSE, it would seem prudent to take reasonable measures to limit exposure of humans (as well as sheep and cattle) to CWD infectivity as has been recommended for other animal TSEs,"

    G.J. Raymond1, A. Bossers2, L.D. Raymond1, K.I. O'Rourke3, L.E. McHolland4, P.K. Bryant III4, M.W. Miller5, E.S. Williams6, M. Smits2 and B. Caughey1,7

    or more recently transmission of BSE to sheep via whole blood Research letters Volume 356, Number 9234 16 September 2000

    Transmission of BSE by blood transfusion in sheep

    Lancet 2000; 356: 999 – 1000

    F Houston, J D Foster, Angela Chong, N Hunter, C J Bostock

    See Commentary

    "We have shown that it is possible to transmit bovine spongiform encephalopathy (BSE) to a sheep by transfusion with whole blood taken from another sheep during the symptom-free phase of an experimental BSE infection. BSE and variant Creutzfeldt-Jakob disease (vCJD) in human beings are caused by the same infectious agent, and the sheep-BSE experimental model has a similar pathogenesis to that of human vCJD. Although UK blood transfusions are leucodepleted--a possible protective measure against any risk from blood transmission-- this report suggests that blood donated by symptom-free vCJD-infected human beings may represent a risk of spread of vCJD infection among the human population of the UK."

    "The demonstration that the new variant of Creutzfeldt-Jakob disease (vCJD) is caused by the same agent that causes bovine spongiform encephalopathy (BSE) in cattle1 has raised concerns that blood from human beings in the symptom-free stages of vCJD could transmit infection to recipients of blood transfusions (full text long version)"

    and...

    "The large number of cases (1040), temporal clustering of the outbreaks (15 in the first 6 months of 1997), the high in-flock incidence, and the exceptional involvement of goats (390 cases), suggested an accidental infection. The source of the epidemic might have been TSE-contaminated meat and bonemeal, but eight flocks had never been fed any commercial feedstuff. Infection might have risen from the use of a formol-inactivated vaccine against contagious agalactia prepared by a single laboratory with brain and mammary gland homogenates of sheep infected with Mycoplasma agalactiae. Although clinical signs of TSE in the donor sheep have not been found, it is possible that one or more of them were harbouring the

    5

    infectious agent. Between 1995 and 1996, this vaccine was given subcutaneously to 15 of the affected flocks (to one flock in 1994) ; in these animals the disease appeared between 23 and 35 months after vaccination. No information is available for herd 13 because it was made up of stolen animals. Sheep from the remaining three flocks (1-3, figure) did not receive the vaccine, thus suggesting a naturally occurring disease.’’ (again, full text long version).

    IN SHORT, please do under estimate this data and or human/animal TSE's including CWD in the U.S.A.

    A few last words, please.

    The cattle industry would love to have us turn our focus to CWD and forget about our own home grown TSE in Bovines. This would be easy to do. Marsh's work was from downer cattle feed, NOT downer deer/elk feed. This has been proven.

    DO NOT MAKE THAT MISTAKE.

    There should be NO LESS THAN 1,000,000 tests for BSE/TSE ' in 2001 for U.S.A. French are testing 20,000 a week. The tests are available. Why wait until we stumble across a case from passive surveillance, by then it is to late. IF we want the truth, this is a must???

    United States Total ,Bovine Brain Submissions by State,

    May 10 ,1990 thru October 31, 2000

    Total 11,700

    FROM 1.5 BILLION HEAD OF CATTLE since 1990 ???

    with same feeding and rendering practices as that of U.K. for years and years, same scrapie infected sheep used in feed, for years and years, 950 scrapie infect FLOCKS in the U.S. and over 20 different strains of scrapie known to date. (hmmm, i am thinking why there is not a variant scrapie, that is totally different than all the rest)? just being sarcastic.

    with only PARTIAL FEED BAN implemented on Aug. 4, 1997??? (you really need to reconsider that blood meal etc. 'TOTAL BAN')


    AND PLEASE FOR GODS SAKE, STOP saying vCJD victims are the only ones tied to this environmental death sentence. "PROVE IT". It's just not true. The 'CHOSEN ONES' are not the only ones dying because of this man-made death sentence. When making regulations for human health from human/animal TSEs, you had better include ALL human TSE's, not just vCJD. Do NOT underestimate sporadic CJD with the 'prehistoric' testing available to date. This could be a deadly mistake. Remember, sCJD kills much faster from 1st onset of symptoms to death, and hvCJD is the fastest. Could it just be a higher titre of infectivity, or route or source, or all three?

    Last, but not least. The illegal/legal harvesting of body parts and tissues will come back to haunt you. Maybe not morally, but due to NO background checks and human TSEs, again it will continue to spread.

    Stupidity, Ignorance and Greed is what fuels this disease. You must stop all of this, and ACT AT ONCE...

    Sent: Monday, January 08,2001 3:03 PM


    FDA CJD BSE TSE Prion Scientific Advisors and Consultants Staff January 2001 Meeting Singeltary Submission

    2001 FDA CJD TSE Prion Singeltary Submission


    MONDAY, JULY 27, 2020 

    ***> BSE Inquiry DFA's a review <***


    Creutzfeldt-Jakob Disease TSE Prion Questionnaires a review 2021

    https://cjdquestionnaire.blogspot.com/2007/11/cjd-questionnaire.html




    CJD TSE PRION ONE IN A MILLION ???

    Prion disease is not one in a million Dec 6, 2018 • ericminikel • Cambridge, MA

    snip...

    Ryan Maddox at the CDC has been doing this for the U.S., and he reported in 2016 that about 1 in every 6,000 deaths is due to prion disease. This figure probably captures some cases that were diagnosed only postmortem or never got referred to the surveillance center, although there might still be some underdiagnosis at work here. 

    Simon Mead has announced a figure of 1 in every 4,700 deaths in the U.K. Coming at it from several different angles and data sources, then, we converge on an answer that roughly 1 in every 5,000 people dies of prion disease, or in other words, the general population’s lifetime risk of prion disease is 1 in 5,000.

    If you’re a researcher studying prion disease or a family affected by prion disease, people probably often ask you “oh, is that super rare?”. Next time this happens, give the best answer you can give: “it kills about 1 in 5,000 people.” Not super common, but not 1 in a million.


    older stats;

    55 year old and greater, the rate of death for sporadic cjd is one in 9,000.

    There is one CJD death per every 6,000 to 10,000 deaths in the U.S. each year. Eighty-five percent of CJD cases are sporadic, meaning there is no known cause at present.


    2008

    The statistical incidence of CJD cases in the United States has been revised to reflect that there is one case per 9000 in adults age 55 and older. Eighty-five percent of the cases are sporadic, meaning there is no known cause at present.


    I kindly would like to bring to everyone's attention;

    ***> 6 Includes 39 case in which the diagnosis is pending (1 from 2018, 1 from 2019, 1 from 2020 and 19 from 2021), and 19 inconclusive cases; 

    WOW, 2021 is showing 19 cases where the diagnosis is pending, and 19 inconclusive cases, what's that all about???

    ***> 7 Includes 33 (33 from 2021) cases with type determination pending in which the diagnosis of vCJD has been excluded. 

    HOLEY COW, WITH 33 ADDITIONAL CASES FROM 2021, WITH TYPE DETERMINATION PENDING, IN WHICH DIAGNOSIS OF VCJD HAS BEEN EXCLUDED, WHAT'S ALL THAT ABOUT??? 

    ***> 8 The sporadic cases include 4158 cases of sporadic Creutzfeldt-Jakob disease (sCJD), 76 cases of Variably Protease-Sensitive Prionopathy (VPSPr) and 35 cases of sporadic Fatal Insomnia (sFI). 

    HOLEY SMOKES, VPSPR CASES SEEM TO BE RISING, no one with a clue if it's zoonotic from cwd, atypical bse, scrapie, iatrogenic there from, or all of the above, take your pick, but with Canada having this outbreak of an neurological disorder similar to cjd, but yet, unlike anything they have seen, and cjd ruled out, yet still no answers, and all these cases of TYPE DETERMINATION PENDING IN THE USA, IN WHICH NVCJD HAS BEEN RULED OUT, AND VPSPR, WHAT'S GOING ON HERE?? WHAT THE HELL IS GOING ON???

    IATROGENIC, IATROGENIC, IATROGENIC. 

    LET'S COMPARE TO LAST REPORTS HERE;

    USA Tables of Cases Examined National Prion Disease Pathology Surveillance Center Cases Examined¹ Updated quarterly.

    Last updated on: October 8th, 2020

    Year Total Referrals² Prion Disease Sporadic Familial Iatrogenic vCJD

    1999 & earlier 382 231 200 27 3 0

    2000 145 102 90 12 0 0

    2001 209 118 110 8 0 0

    2002 241 144 124 18 2 0

    2003 259 160 137 21 2 0

    2004 316 181 164 16 0 1³

    2005 327 178 156 21 1 0

    2006 365 179 159 17 1 2⁴

    2007 374 210 191 19 0 0

    2008 384 221 205 16 0 0

    2009 397 231 210 20 1 0

    2010 401 246 218 28 0 0

    2011 392 238 214 24 0 0

    2012 413 244 221 23 0 0

    2013 416 258 223 34 1 0

    2014 355 208 185 21 1 1⁵

    2015 401 263 243 20 0 0

    2016 396 277 248 29 0 0

    2017 375 266 247 19 0 0

    2018 309 223 204 18 1 0

    2019 422 274 252 21 0 0

    2020 252 159 125 11 1 0

    TOTAL 75316 46117 41268 4439 14 4

    1Listed based on the year of death or, if not available, on the year of referral; 

    2Cases with suspected prion disease for which brain tissue was submitted; 

    3Disease acquired in the United Kingdom; 

    4Disease acquired in the United Kingdom in one case and in Saudi Arabia in the other; 

    5Disease possibly acquired in a Middle Eastern or Eastern European country; 

    6Includes 12 cases in which the diagnosis is pending, and 19 inconclusive cases; 

    7Includes 24 (1 from 1986, 1 from 2019, 22 from 2020) cases with type determination pending in which the diagnosis of vCJD has been excluded. 

    8The sporadic cases include 4020 cases of sporadic Creutzfeldt-Jakob disease (sCJD), 71 cases of Variably Protease-Sensitive Prionopathy (VPSPr) and 35 cases of sporadic Fatal Insomnia (sFI). 

    9Total does not include 277 Familial cases diagnosed by blood test only.


    snip...see full text;


    OHIO Creutzfeldt Jakob Disease


    see BIG CJD JUMP 2017!

    REPORTED CASES OF SELECTED NOTIFIABLE DISEASES BY YEAR OF ONSET, OHIO, 2013-2017

    GENERAL INFECTIOUS DISEASES 2013, 2014, 2015, 2016, 2017

    Creutzfeldt-Jakob Disease (CJD) 8 0.1 12 0.1 8 0.1 4 0.0 20 0.2 8 0.1 10 0.1

    REPORTED CASES OF SELECTED NOTIFIABLE DISEASES BY AGE IN YEARS, OHIO, 2017

    Creutzfeldt-Jakob Disease (CJD) 3 0.2 5 0.3 12 0.4 0 n/a 20 0.2

    REPORTED CASES OF SELECTED NOTIFIABLE DISEASES BY SEX, OHIO, 2017

    Creutzfeldt-Jakob Disease (CJD) 8 0.1 9 0.2 3 n/a 20 0.2

    REPORTED CASES OF SELECTED NOTIFIABLE DISEASES BY MONTH OF ONSET, OHIO, 2017

    Creutzfeldt-Jakob Disease (CJD) 1 5% 2 10% 0 0% 2 10% 2 10% 0 0% 1 5%



    Thursday, October 28, 2021 

    Chronic Wasting Disease (CWD) TSE Prion Zoonosis, friendly fire, iatrogenic transmission, blood products, sporadic CJD, what if?


    SATURDAY, NOVEMBER 06, 2021 

    Texas adopts new management rules for chronic wasting disease in deer Nov 6, 2021


    Terry S. Singeltary Sr.

    0 Comments:

    Post a Comment

    Subscribe to Post Comments [Atom]

    << Home